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Abstract
Most peptide hormones are initially synthesized within a larger precursor protein and 
processed by a series of enzymes to the active molecule. Although much work has 
been undertaken in this field, many details of these reactions are not fully 
understood.
The biosynthesis of oxytocin and vasopressin involve at least three distinct processing 
activities which occur sequentially within the environment of the neurosecretory 
granule. Studies of granular extracts have identified the presence of all the 
individual activities; however, diverse conditions such as pH and cofactors have so 
far prevented the in vitro observation of complete processing from prohormone to 
active hormone in a single preparation.
The aim of this study, therefore, is to identify environmental factors which may 
operate in vivo to allow activity of all the processing enzymes under a common set of 
conditions.
I. Synthetic oxytocin-Gly-Lys-Arg was used as a substrate for a preparation of 
bovine neurosecretory granules containing carboxypeptidase E activity. The 
cleavage rate of the carboxy terminal arginine residue was affected by the 
presence of a range of proteins, including neurophysin, and this affect was shown
to be unrelated either to the presence of sulphydryl groups or to 
neurophysin-substrate binding. Carboxypeptidase E activity increased by fifty to 
one hundred percent in the presence of proteins at low concentrations (up to 
lOOpM), while at 500jiM protein this stimulation was lessened and under some 
conditions activity was inhibited. Treatment of the substrate to prevent it from 
binding to neurophysin was used to show that neurophysin can stimulate enzyme 
activity equally well whether or not it is binding the substrate.
II. Differences were shown between soluble and membrane-associated 
carboxypeptidase E activities in terms of both substrate specificity and response 
to changing pH. Although the membrane preparation cleaved carboxy terminal 
arginine more slowly than did the soluble enzyme, it was capable of cleaving the 
remaining lysine residue, a reaction that was not observed with the soluble 
preparation.
III. This study has shown that the activity of a widespread prohormone processing 
enzyme, carboxypeptidase E, is indeed influenced by environmental factors, 
including protein concentration and proximity to the granule membrane, which 
are likely to be operating in vivo. There is evidence that the soluble and 
membrane-bound forms of the enzyme are capable of fulfilling different roles. 
The presence of these two forms in the neurosecretory granule could be explained
by their different relative activities with the two substrate molecules. The 
soluble form may react more quickly with the arginyl substrate, while the 
membrane-bound enzyme is more efficient at cleaving the lysyl peptide.
These results should be considered in future studies of hormone biosynthesis if 
integrated approach to the study of complete processing is to be followed.
CHAPTER 1:
PRODUCTION OF OXYTOCIN AND VASOPRESSIN
1.1. The Neurohypophyseal Hormones
1.1.1. Introduction
The mammalian neurohypophysis was shown early this century to possess four 
biological activities, namely uterotonic, milk-ejecting, pressor and antidiuretic 
properties (for review see Heller, 1974). There followed much controversy as to the 
number of peptides or proteins responsible for these properties until du Vigneaud and 
colleagues, in the 1950's, isolated oxytocin and vasopressin, determined their 
structures and established their activities using synthetic peptides (see du Vigneaud, 
1957). Oxytocin possesses uterotonic and milk-ejecting properties, while vasopressin 
is responsible for pressor and antidiuretic functions, although the similarity in 
structures accounts for some overlap in activities. Both peptides consist of nine 
amino acids, with a ring formed between the two cysteine residues at positions one 
and six; the carboxy terminal amino acid (glycine) has an a-amino group. The two 
hormones differ at only two positions, in the ring at position three, and in the tail at 
position eight (figure 1.1).
Neurohypophyseal oxytocin and vasopressin are in fact synthesized by different 
cells in the paraventricular and supraoptic nuclei (cell groups) of the hypothalamus
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(Mohr et al, 1988b). Both hormones are produced by magnocellular neurones in 
these areas; vasopressin is also made by parvicellular neurones in the suprachiasmatic 
nuclei, and axons from all these sites project to the posterior pituitary via the median 
eminence (figure 1.2). Some axons from the paraventricular nucleus also terminate in 
the median eminence itself and in extrahypothalamic areas of the brain and spinal 
cord.
The hormones are stored within the neurohypophysis inside granules that 
accumulate in axonal swellings (Herring bodies); the axons are supported by the 
surrounding pituitary cells (pituicytes) and account for about 40% of the total volume 
of the neurohypophysis (Nordmann, 1977). Action potentials passing down the axons 
from the hypothalamus lead to an increase in the concentration of calcium ions in the 
axonal cytoplasm; this causes exocytosis of the granules and release of oxytocin and 
vasopressin into the extracellular space (for review see Poulain & Wakerley, 1982); 
there is a preferential release of newly-arrived granules over older ones (Sachs & 
Haller, 1968, Norstrom & Sjostrand, 1972 and Wong & Pickering, 1976).
Hormone from the neurohypophysis is released into the systemic circulation to 
fulfill endocrine roles. Vasopressin liberated in the median eminence enters the 
portal blood supply to the anterior pituitary, and is thought to act there as a releasing 
hormone of adrenocorticotropin (ACTH) (Carlson et al, 1982). Both hormones have 
been identified in diverse areas of the brain and spinal cord where their functions are 




For a review of hormone activities, see Baylis & Padfield (1985). Oxytocin is 
released from the pituitary in episodic secretion, and due to a fairly short half life (3- 
17 min), plasma levels are constantly fluctuating. Release is stimulated in the female 
by stretching of the lower genital tract (Ferguson's reflex) and tactile stimulation of 
the nipple. These physical stimuli are modulated by factors such as the presence of 
oestrogens, which stimulate oxytocin release (Robinson et al, 1977), 
neurotransmitters (see Richard et al, 1985) and the emotional status of the animal.
Oxytocin can cause contraction of smooth muscle in the uterus and the breast, 
but its effectiveness depends directly on the numbers of oxytocin receptors in these 
tissues, and this is in turn dependent on the reproductive state of the animal. Again, 
oestrogens play a role by stimulating the expression of oxytocin receptors in uterine 
tissue in late pregnancy (Solof et al, 1979). An increase in receptor numbers occurs 
in the breast, but this is not thought to be initiated by increased oestrogen 
concentrations (Solof et al, 1979).
Plasma levels of oxytocin rise towards the end of pregnancy, and exhibit a 
maximum during the expulsive phase of labour. Receptors in the uterus appear only 
in late pregnancy and disappear rapidly after parturition; a single injection of 
oxytocin at this stage will cause a series of muscular contractions which continue 
after the hormone has been cleared from the circulation. Receptor numbers change 
less in the mammary gland, and although there is some increase after parturition, a 
similar injection of oxytocin will only cause a single contraction in the 
myoepithelium of the breast (Lincoln & Paisley, 1982).
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The physiological function of oxytocin in labour is uncertain; it can be used to 
artificially induce parturition in late pregnancy, but is not thought to be needed for 
normal initiation of labour. It may be involved in retraction of the uterus after 
delivery or constriction of the uterine and umbilical vessels, where it is a more 
powerful vasoconstrictor than vasopressin, to prevent excessive bleeding after 
expulsion of the placenta (see Chard, 1985). In lactation, oxytocin causes milk 
ejection, but again the importance of the hormone in this activity is uncertain; milk 
let-down often occurs before suckling begins, when oxytocin levels are low. The 
increases in receptor numbers in these tissues during late pregnancy, however, may 
cause them to become unusually responsive to "basal" levels of circulating hormone 
(Solof et al, 1979), so oxytocin could indeed trigger initiation of labour and milk 
ejection. Observations of substantial oxytocin gene activity in the male 
hypothalamus suggest an endocrine role for oxytocin in the male (Richter, 1985).
Release of vasopressin is stimulated by osmotic stress and blood volume 
depletion (for review see Robinson & Verbalis, 1987). The osmotic response is 
exquisitely sensitive and secretion is triggered by as little as a 1% change in plasma 
osmolality. Vasopressin acts to combat osmotic stress by causing increased water 
resorption in the distal tubules of the kidney; this water dilutes the plasma, increasing 
its volume and reducing its osmolality. Secretion of vasopressin can also be induced 
by a drop in blood volume, but a 5-10% decrease in volume is needed to activate this 
pathway (see Robertson, 1977). Although vasopressin release is much less sensitive 
to this trigger, when a response occurs it can result in much higher levels of 
vasopressin in the circulation; up to ten times those occurring due to a hyperosmotic 
stimulus (Robertson, 1977). These levels are sufficient to cause vasoconstriction and
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so provide a rapid correction of the pressure loss experienced by a sudden decrease in 
blood volume. While vasopressin acts as a constant sensitive adjustment mechanism 
for plasma osmolality, its function in maintaining blood volume is probably not 
operating under normal physiologic circumstances but is a fast response to an acute 
drop in volume, such as in haemorrhage. Vasopressin is also released in response to a 
decrease in blood pressure. A drop of 5% in the human, which is within normal daily 
fluctuations in a healthy adult, can result in a significant increase in plasma 
vasopressin (Robertson, 1977).
1.1.3. Gene Structure and Translation Products
The genes which code for oxytocin and vasopressin have been isolated and 
sequenced from rat (Schmale et al, 1983 and Ivell & Richter, 1984), cow (Ruppert et 
al, 1984) and human (Sausville et al, 1985). Complementary DNA (cDNA) has also 
been cloned from the mRNA for bovine vasopressin (Land et al, 1982) and oxytocin 
(Land et al, 1983), and comparison of the genomic DNA and cDNA reveal a common 
structure for the two genes, suggesting they have evolved from a single ancestral 
gene.
All the genes sequenced to date are less than 2.5kb in size, with the vasopressin 
gene typically about lkb larger than the oxytocin gene. The structure comprises three 
exons, A, B and C, and two introns (figure 1.3). The resulting (bovine) translation 
products are proteins of 166 amino acids for vasopressin and 125 amino acids for 
oxytocin (Land et al, 1982 and Land et al, 1983). The sizes of these proteins are 
obviously far in excess of the hormones themselves which are each only 9 amino 
acids long. Like many other peptide hormones and neuropeptides, oxytocin and
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vasopressin are synthesized as parts of larger precursor proteins. The gene 
organization that leads to this synthesis is shown in figure 1.3.
The resulting translation product consists of a signal peptide, the 9 amino acids 
of the hormone, and the sequence of a small protein called neurophysin. The 
vasopressin precursor has an additional carboxy terminal glycoprotein domain of 39 
amino acids. In both cases the hormone and neurophysin sequences are separated by 
3 amino acids, Gly-Lys-Arg, and the neurophysin sequence is followed by a single 
residue of either Arg or His. In this form the protein is known as a preprohormone, 
and after removal of the signal peptide simply as a prohormone. The processing of 
these precursor molecules to the active hormones is detailed in section 1.2.
1.1.4. Genetic Control and Conservation
Where studied, the two genes occur close together on opposite strands of the 
same chromosome. In the human, they are both on chromosome 20 (Riddell et al,
1985), 12kb apart (Sausville et al, 1985), and in the rat 1 lkbp apart (Mohr et al, 
1988a). Although the levels of transcription of both genes appear to respond to the 
same stimuli, for example osmotic stress (Mohr et al, 1988b) and lactation (Zingg & 
Lebebvre, 1988), the two genes are never active in the same cell (Mohr et al, 1988b). 
This would suggest that while some factors are able to act on control regions of both 
genes, there must be important differences at these sites to prevent transcription of 
both genes in the same nucleus.
Studies in the rat show homology at the 5'-flanking regions of both genes (the 
putative promoter regions), including some potential control sites; this area of the 
oxytocin gene for instance includes sequences that may be responsive to
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glucocorticoids and some to oestrogens, as well as a possible interferon-responsive 
enhancer sequence (Mohr et al, 1988a). Some similarity is seen in the vasopressin 
gene, which also contains a consensus sequence for a glucocorticoid response 
element, but this gene possesses a region resembling a cAMP response element and 
four putative AP2 (transcription factor) binding sites (Mohr & Richter, 1990).
Protein sequencing studies on the neurophysins revealed that within each 
species the two types (from prooxytocin and provasopressin) differ by about 20%; 
however, between species the substitution rate is much lower, only 1-5% in 
neurophysins from provasopressin and 6% in the proteins from prooxytocin (for 
review see Acher, 1980). This apparently high level of conservation between various 
mammalian species was confirmed when the gene sequences became available. Not 
only is there a high degree of homology in the sequences for the corresponding rat, 
bovine and human genes, there also emerged extensive nucleotide homology between 
the two different genes of each species, with over 99% homology in each case for the 
sequence encoded by exon B. This level of homology is far higher than would be 
expected even for two genes coming from a common ancestor, particularly because 
of the absence of silent mutations, which are not prevented by conservation of amino 
acid sequence. The likely explanation, therefore, is of gene conversion events 
involving the second exon of both genes and part of the first intron, extending 
upstream of exon B (where homology is also seen). The ancestral gene is thought to 
have undergone duplication and divergence to give the oxytocin and vasopressin 
lineages before the appearance of fishes 450 million years ago (Acher, 1980). 
Calculations using the mutation rate for silent substitutions suggest that conversion of
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the central regions of the genes occurred about 10 million years ago in the rat, and 
less than 1 million years ago in the bovine gene (Ruppert et al, 1984).
While gene conversion can account for conservation of the central sequence of 
the two neurophysins within a given species, the high level of homology seen 
between species cannot be explained in this way, and is therefore perhaps due to an 
important function played by these proteins that is dependent upon their sequence.
1.1.5. Neurophysins
Neurophysins are stable, cysteine-rich proteins of about lOkd, encoded by the 
oxytocin and vasopressin genes. They were first isolated by Acher and Fromageot 
(1957) from a noncovalent complex with the two hormones (the "van Dyke protein"). 
Further work revealed that neurophysin specifically binds both hormones with high 
affinity and that at least two types of neurophysin could be isolated from most species 
studied (for review see Hope, 1975). When neurophysin was found to be synthesized 
as part of the hormone precursor, it was clear that the two forms of the protein 
correlated with the two different precursors. Nomenclature of the neurophysins has 
become confusing, based on relative electrophoretic mobilities or amino acids at 
certain positions, as proteins from different species do not give a consistent 
classification; it is easier to refer to them, therefore, by their origin from prooxytocin 
as oxytocin-neurophysin (OT-Np), or from provasopressin as vasopressin- 
neurophysin (VP-Np).
Although neurophysins also occur with neurohypophyseal hormones in non­
mammalian species, studies into structure and hormone binding have been conducted 
using only mammalian neurophysins (for reviews see Breslow, 1979 and Breslow &
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Burman, 1990). The amino acid sequences of neurophysins from several mammalian 
and non-mammalian species are shown in figure 1.4. As already stated, these 
proteins show a very high degree of conservation both within and between species, 
particularly in the central region that is encoded by exon B. Other features of the 
primary sequence include a high cysteine content, 14 out of 93-95 residues, and 
internally duplicated segments at residues 12-31 and 60-77 showing about 60% 
homology (Capra et al> 1972).
Predictions of secondary structure suggest a low content of a-helix (5-20%) and 
about 40% p-pleated sheet (Breslow, 1979). The tertiary structure is highly stable 
due to the involvement of all 14 cysteine residues in disulphide bonds; all of the pairs 
have been assigned and reveal the formation of two separate domains with similar 
pairing patterns within each domain (Burman et al, 1989) (see figure 1.5).
Neurophysin binds both hormones in a 1:1 molar ratio, and extensive studies 
have been undertaken using both hormones and smaller peptide analogues in order to 
identify the residues involved in binding, both in the hormone and neurophysin 
sequences (for review see Breslow, 1979). The hormone residues important for 
binding are relatively easy to study using synthetic analogues; this has shown the 
major involvement of the a-amino group and the side chains of the first three amino 
acids in the hormone sequences. The protonated a-amino group of the hormone 
forms a salt-bridge with an ionized carboxyl on the side-chain of a neurophysin 
residue which has not yet been identified; this bond accounts for the pH dependence 
of the hormone-neurophysin interaction, which is maximal at pH 5-6 and declines 
rapidly below pH 5.0 and above pH 6.5. The hormone side chains of Cys^, Tyr^ and 
Phe^ or Ile^ contribute to the binding with hydrophobic interactions with the protein;
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the presence of a hydrophobic aromatic residue at position 2 (either tyrosine or 
phenylalanine) is essential for hormone-neurophysin binding (Breslow, 1975). 
Although a synthetic tripeptide based on these three residues will bind to 
neurophysin, it does so with lower affinity suggesting that other residues in the 
hormone sequence or the conformation of the hormone molecule are involved in 
stabilizing the binding (Breslow, 1975). In solution, neurophysin exists in an 
equilibrium between monomeric and dimeric forms, and dimerisation potentiates 
hormone binding; neurophysin dimers are stabilized by the addition of phosphate 
ions, although this is not believed to be significant under normal physiological 
conditions (Tellam & Winzor, 1980).
Little is so far know about the hormone binding site on the neurophysin 
molecule (see Breslow & Burman, 1990). Chemical cross-linking suggests the 
contribution of the carboxyl group for the salt bridge by Glu^l (Walter & Hoffman, 
1973), and neurophysin Arg^ has been shown by circular dichroism studies to 
stabilize the bound state (Breslow et al, 1989). Much work has also been conducted 
into the role of T y r^  in hormone binding, with evidence of involvement of this 
residue from studies using, among other techniques, photoaffinity labelling 
(Abercrombie et al, 1982), nuclear magnetic resonance spectroscopy (Peyton & 
Breslow, 1985) and chemical cross-linking (Sardana et al> 1987). All three of these 
residues occur in the "amino domain" of neurophysin as deduced by Burman et al 
(1989) from disulphide pairing (see figure 1.5), and they are also conserved 
throughout the mammalian neurophysins so far studied (see figure 1.4). However, 
sequences of non-mammalian neurophysins reveal that although Arg^ appears in all 
of these sequences, in frog and toad VP-Np the A sp^-G lu^  pair is reversed (Michel
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et al, 1987 and Nojiri et al, 1987); in one fish neurophysin the glutamine is again 
moved to position 30, and in another it is absent (Heierhorst et al, 1989). T y r^ , 
about which there is most evidence of binding involvement, does not occur in one of 
the neurophysins from both ostrich (Chauvet et al, 1986) and toad, but these 
molecules both have a tyrosine at position 35 which is not seen in mammalian 
neurophysins. Two neurophysins of the white sucker fish Catostomus commersoni 
(which has at least three neurophysin species due to duplication of the vasotocin 
gene) also lack T yr^: one has a tyrosine at position 22 and the other at position 63; 
thus the second fish neurophysin is the only one that does not have a tyrosine residue 
in the amino domain of the protein (Heierhorst et al, 1989).
The high degree of evolutionary conservation of the neurophysins suggests an 
important role for these proteins. Evidence has been presented that neurophysin can 
act as a growth factor for the non-neuronal glial cells found at the site of neurophysin 
synthesis in the hypothalamus (Worley & Pickering, 1984). Several studies looking 
for physiological effects of neurophysin outside the hypothalamo-pituitary system 
revealed apparent lipolytic, hypocalcaemic, hyperglycaemic and melanotropic 
actions, but these have since been shown to have resulted from contamination of the 
neurophysin preparations (for review see Pickering & Jones, 1978). The only 
activities of neurophysin so far confirmed, then, are the potential to promote cell 
growth in the hypothalamus and the ability to bind hormone at acid pH; the 
dissociation of the complex at a neutral pH discounts neurophysin from acting as a 
carrier for the hormone in the circulation. Its importance would therefore appear to 
lie in the formation of the hormone-neurophysin complex within the neurosecretory 
granule, which has an acidic nature (Russell & Holz, 1981 and Sherman &
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Nordmann, 1982). The purpose of this binding has been variously suggested as being 
to prevent leakage of hormone out of the granule, to prevent disulphide interchange 
between hormone molecules, or to protect the hormones from proteolysis (Breslow, 
1979). The finding that most of the hormone-neurophysin complex is present in the 
granule in a crystalline form (Nordmann and Morris, 1984) has also led to the 
suggestions that the binding acts to reduce the osmotic potential within the granule 
(Breslow, 1979), or to assist in driving packaging of the precursor molecules into 
granules at the Golgi apparatus (Rose et al, 1988 and Breslow & Burman, 1990). 
Aggregation of individual molecules into larger complexes would reduce the apparent 
concentration gradient caused by packaging and thus reduce the energy requirement. 
Evidence against these ideas comes mainly from the existence of other small peptide 
hormones which are successfully packaged and stored in similar granules and do not 
appear to suffer from leakage, proteolysis or osmotic problems, although they are not 
known to be bound by any protein within the granule. Thus the confirmation of a 
role for these apparently important proteins is still lacking.
1.1.6. Extrahypothalamic Synthesis
Oxytocin and vasopressin have commonly been identified by 
immunohistochemistry, radioimmunoassay or high performance liquid 
chromatography (hplc) in areas other than the hypothalamus and pituitary, such as the 
adrenal, placenta and ovary (for review see Ivell, 1987). Initially it was not known 
whether the hormone found in these organs derived from the hypothalamus or was in 
fact being made in these areas. Ovarian synthesis was confirmed by incorporation of 
[■^S]-cysteine into oxytocin by cells of the corpus luteum (Swann et al, 1984) and
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discovery of preprooxytocin mRNA in luteal extracts (Ivell & Richter, 1984). 
Knowledge of the mRNA sequences for the preprohormones makes it possible to 
determine the exact sites of precursor synthesis using cDNA or cRNA probes for 
precursor mRNA, and this technique has located preprooxytocin mRNA in the cell 
bodies of magnocellular neurones in the supraoptic, suprachiasmatic and 
paraventricular nuclei of the rat hypothalamus (Mohr et al, 1988b), as well as the 
bovine corpus luteum (Ivell & Richter, 1984), rat cerebellum and testis (Ivell et al,
1986), and human thymus (Geenan et al, 1987). The functions of oxytocin and 
vasopressin synthesized outside the hypothalamus are uncertain, but ovarian oxytocin 
is believed to play a role in luteolysis (Flint & Sheldrick, 1985), and the hormone is 
seen to cause increased contractility of rat seminiferous tubules in vitro (Worley et al, 
1985).
1.1.7. Evolution of Neurohypophyseal Hormones
After the initial identification of oxytocin and vasopressin in the 1950's, du 
Vigneaud's group synthesized various analogues of the hormones including arginine 
vasotocin, which has the ring of oxytocin and the tail of vasopressin, and showed 
similar pharmacological characteristics to chicken pituitary extracts. Meanwhile, 
Heller in Bristol was looking for the "water balance principle" in fish, amphibians 
and birds, known to be a molecule with pressor and oxytocic activities, but not 
vasopressin or oxytocin. The two groups met and the unnamed molecule was 
identified as vasotocin (see Pickering, 1985).
Chemical studies of hormones related to oxytocin and vasopressin have been 
carried out so far almost exclusively in vertebrates resulting in the identification of
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ten peptides (table 1.1), although extensive immunocytochemical studies have been 
conducted in insects and coelenterates with positive results (Mizuno & Takeda, 1988a 
and Mizuno & Takeda, 1988b) and a molecule related to vasotocin has been isolated 
from locusts (Cupo & Proux, 1983 and Proux et al, 1987). Most of the fifty or so 
vertebrate species studied have two neurohypophyseal hormones, one related to 
oxytocin and one to vasopressin. The relationship to the mammalian hormones is 
decided by the nature of the amino acid at position eight; in oxytocin-like peptides 
this is neutral while in vasopressin-like peptides it is a basic amino acid. This family 
of hormones exhibits strong evolutionary stability; they share a common basic 
structure, with the same pairs of peptides being present in related species and amino 
acid substitutions usually only involving one or two amino acids.
The evolutionary pathway of this hormone family is not entirely clear (for 
review see Acher & Chauvet, 1988); their presence in vertebrate species is shown in 
table 1.2. Cyclostomes, the most ancient surviving vertebrates, appear to have only 
vasotocin. A peptide has been isolated from locusts which has the same basic 
structure as these hormones (nine amino acids, 1-6 forming a ring, and a carboxy 
terminal amide), and is most closely related in sequence to vasotocin (Ile^ and Arg^). 
Vasotocin is also thought to be present in all non-mammalian vertebrates, so this 
seems the most likely of the hormones to have been present at the beginning of 
vertebrate evolution. In attempting to follow the possible development of the 
hormones by gene duplication and single base changes as the vertebrates evolved, it 
must be remembered firstly that only a limited number of present day species have 
been studied, so there may be more hormones as yet undiscovered, and secondly that 
the species alive today have continued to evolve from their ancestral forms for
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millions of years and do not represent an unaltered sequence of evolutionary types. 
With these facts in mind, a possible pathway of evolution has been suggested for the 
neurohypophyseal hormones (figure 1.6).
The evolution of the vasopressin line appears straightforward. Vasotocin 
persisted in the non-mammalian vertebrates, then was replaced by arginine 
vasopressin in early mammals, where it is seen now in the primitive prototherian 
echidnas. The change from vasotocin to arginine vasopressin, Ile^ to Phe^, requires 
only a single base substitution. Arginine vasopressin remains present in eutherian 
mammals, except where another single base change has given rise to lysine 
vasopressin, identified in the pig (Popenoe et al, 1952) and Peruvian mouse (Stewart, 
1968). In marsupials, an apparent duplication of the vasopressin gene has led to some 
species exhibiting two vasopressin-like peptides; in Australian Macropodidae and 
Peramelidae, both lysine vasopressin and phenypressin (which could again be 
produced from arginine vasopressin by a single base change) are seen (Chauvet et al, 
1983), whereas in American opossums arginine and lysine vasopressins are found 
together (Chauvet et al, 1985).
The lineage of oxytocin is harder to follow. An initial duplication of the 
vasotocin gene before the appearance of the fishes would have allowed mutation of 
the duplicate gene to give rise to this new line of peptides, but it is not possible to 
follow it through vertebrate groups with only single base alterations as can be done 
with the vasopressin line. The major problem is that three of the four oxytocin-like 
peptides found in fishes, namely isotocin, glumitocin and aspargtocin, have residues 
at position 4 that cannot be reached by a single base change from Gln^ in vasotocin. 
Similarly, Ser* in isotocin would have to go through Pro to become Gln^ again in
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mesotocin, which is the presumed path of development (from bony fishes to 
tetrapods). It may be that proline has appeared in position 4 and that this hormone 
has either been lost in evolution or not yet identified. A synthetic analogue of 
vasopressin, Pro^-Arg^-vasopressin, exhibits some antidiuretic activity (Buku et al,
1987), so Pro^-vasotocin may be a viable hormone. Conversely, an early gene 
duplication could have given rise to the fish peptides after the separation of fishes 
from the tetrapod lineage, where another gene duplication event would allow a single 
base change to produce mesotocin from vasotocin (Arg^ to Ile^). Another point 
mutation in mesotocin will produce oxytocin. As with the vasopressin peptides, some 
marsupials appear to display duplication of the oxytocin-like hormones; both 
oxytocin and mesotocin have been found in the North American opossum (Chauvet et 
al, 1984) and the Australian Northern bandicoot (Rouille et al, 1988).
The possible evolutionary connections between vasotocin and arginine 
vasopressin, as well as mesotocin and oxytocin are strongly supported by evidence of 
precursor structure from cDNA sequencing. Studies using the bufo toad show that 
provasotocin has a structure similar to provasopressin (hormone, neurophysin and 
glycopeptide moieties) while promesotocin, like prooxytocin, lacks the glycopeptide 
domain (Nojiri et al, 1987). The same investigation also provided evidence of a gene 
conversion event in the toad similar to those suggested for mammals, involving the 
central region of the neurophysins. This has also been suggested from neurophysin 
sequence studies in birds (L6vy et al, 1987). The recent cDNA sequencing of 
vasotocin and isotocin precursors from the teleost fish Catostomus commersoni has 
provided more information about the possible evolutionary pathways of the 
hormones; both precursors contain a carboxy terminal sequence after neurophysin
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which exhibit some homology with the glycopeptide moiety of provasotocin from the 
toad (Heierhorst et al, 1989). This strengthens the connection between the vasotocin 
genes in the fish and the toad, but does not support the evolution of promesotocin 
from proisotocin as the two prohormones have different structures.
It should be noted that the theory of vasotocin being the sole original vertebrate 
peptide is brought into doubt by some immunohistochemical studies suggesting the 
presence of both oxytocin-like and vasotocin/vasopressin-like immunoreactivities in a 
wide range of invertebrates (eg. Mizuno & Takeda, 1988a and Mizuno & Takeda, 
1988b). These results support a gene duplication at a much earlier stage of evolution, 
although this could have occurred after the ancient divergence of the invertebrate and 
vertebrate lines. However, duplication of both genes in some marsupials, as well as 
the discoveries of duplicate vasotocin genes in the sucker fish (Heierhorst et al, 1989) 
and chum salmon, Oncorhynchus keta (Heierhorst et al, 1990), may demonstrate 
particular susceptibility of the genes to duplication. There is also evidence for 
duplication of the vasopressin gene in pig, which appears to express both arginine and 
lysine vasopressins in the testis (Nicholson et al, 1988). In the Brattleboro rat, which 
is deficient in vasopressin,some neurones in the magnocellular system have been 
reported to be immunoreactive for both vasopressin and the associated glycopeptide 
(Richards et al, 1985). The deficiency is caused by a base deletion in exon B 
(Schmale & Richter, 1984), so the region of the gene which normally codes for the 
glycopeptide domain is subject to a frame-shift and consequent loss of sequence, 
glycosylation site and stop codon (with translation continuing into the poly-A region). 
The apparent presence of immunoreactive glycopeptide in a particular cell group of 
these animals is therefore unexpected and could be explained by the expression of a
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duplicate, unaffected vasopressin gene in these cells. However, the apparent 
difficulty that these cells encounter in packaging and transporting the immunoreactive 
material (Richards et al, 1985) may indicate that alternative splicing of the mutant 
transcript is occuring, joining exon A (which codes for the hormone sequence) 
directly to exon C (which includes the glycopeptide region), so overcoming the 
frame-shift and resulting in a product containing both of the immunoreactive regions, 
but which cannot be processed normally by the cell.
Despite the unlikelihood of a second vasopressin gene in the Brattleboro rat, 
there is much evidence of several gene duplication events in the evolution of the 
neurohypophyseal hormones. This may allow the possibility of a single vasotocin 
gene entering the vertebrate line; the first duplication after divergence of the fishes 
producing isotocin, and the second during early tetrapod evolution, where the 
duplicated gene this time lost its carboxy terminal extension, giving rise to mesotocin. 
The oxytocin family would then have evolved at least twice (i.e. parallel evolution), 
once in fish, and again in higher vertebrates.
1.2. Prohormone Processing
1.2.1. Introduction
Many functional proteins are made as integral parts of longer precursor 
molecules; for example albumin, catalase, melittin and zymogens, as well as peptide 
hormones, are initially synthesized within polyprotein sequences (for review see 
Zimmerman et al, 1980). The purpose behind synthesizing proteins in this way is not
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always clear, although it is obviously important to store certain enzymes in an 
inactive state to prevent cell damage, and this can be achieved by synthesis of an 
inactive precursor, or zymogen. In other cases it may be necessary to ensure correct 
folding of the mature peptide, as in the case of insulin (Steiner, 1974), or to provide 
the minimum size of protein that can be translocated and packaged by the cell, or 
perhaps to coordinate synthesis of different active molecules contained within the 
same precursor sequence (Docherty & Steiner, 1982).
The enzyme activities involved in the processing of peptide prohormones 
generally include specific endoproteolysis to release the hormone domain from the 
bulk of the precursor, followed by trimming of excess residues at one or both ends by 
amino- or carboxypeptidase activities. The hormone sequence is then commonly 
modified by such reactions as amino terminal acetylation or, as with oxytocin and 
vasopressin, carboxy terminal amidation (Loh et al, 1984).
The action of selective enzymes on precursor molecules is thus widespread in 
nature and can serve diverse purposes (Zimmerman et al, 1980). A single 
polyprotein can be cleaved to release several peptides with related functions. For 
example in viral reproduction the enzymes and structural proteins required for 
complete replication and assembly of the new virion can be contained within a single 
precursor molecule; this allows both coordination of synthesis of all the components 
needed for the replicative process and efficient use of genetic material (Koch & 
Richter, 1980). Identical precursor proteins can also be differentially processed to 
give rise to appropriate products in different tissues and/or at varying stages of 
development. An example of this tissue specific processing is seen in the proteolysis 
of pro-opiomelanocortin (POMC) in the mammalian pituitary; in the anterior lobe the
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primaiy products are adrenocorticotropin (ACTH) and p-lipotropin, while the 
neurointermediate lobe produces mainly a-melanocyte stimulating hormone, 
corticotrophin-like intermediate lobe peptide, %-lipotropin and p-endorphin (Roberts 
et al, 1978). Differential processing of this kind could be achieved by several tissue- 
specific properties, including differences in processing enzymes, intracellular 
compartmentalization of precursor or enzymes, and accessibility of different 
processing sites within the precursor sequence by structural modification due to 
different environmental conditions (Thomas et al, 1988a).
Tissue-specific processing can also affect the activity of a peptide as well as its 
quantity in a given tissue. For example, differential processing of p-endorphin (a 
product of POMC) in the regions of the pituitary can result in widely differing 
activities in the anterior and intermediate lobes with little difference in quantity 
(Smyth & Zakarian, 1980).
During sexual development of the female rat, changes in the processing of p- 
endorphin in the hypothalamus and pituitary have been detected (Martensz, 1985). 
While processing of POMC to P-endorphin in the anterior lobe increases during this 
time, the levels of active p-endorphin in the hypothalamus are reduced in the mature 
animal by increased carboxy terminal proteolysis; this decrease in active P-endorphin 
may allow an increase in the secretion of lutenizing hormone and onset of 
reproductive activity (Martensz, 1985). Ontogenic differences in the processing of 
prooxytocin have also been described (Altstein & Gainer, 1986 and Altstein et al,
1988) which allow control of the level of oxytocin found in the hypothalamo- 
neurohypophyseal system of the rat at different stages of development.
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Thus, precursor processing can be important in determining the type, quantity 
and potency of bioactive products from a single precursor. It is also necessary to 
understand the processes involved if such peptides are to be produced by gene 
cloning and fermentation methods, as the initial translation product needs to be 
processed correctly and efficiently in order to obtain the active peptide.
The primary sequences of many prohormones have been elucidated from cloned 
cDNA or genomic DNA fragments (for review see Douglass et al, 1984); similarities 
can be seen between all of these molecules. As the final products are destined for 
export from the cell, the precursors like all secretory proteins have an amino terminal 
signal peptide of 18-25 hydrophobic amino acids. This sequence facilitates co- 
translational translocation of the preprohormone into the lumen of the rER, where the 
signal peptide is removed by a specific endoprotease (Lingappa & Blobel, 1980).
The remaining prohormone may contain a single active hormone sequence, as in 
probradykinin (Nawa et al, 1983), several different active sequences such as within 
POMC (Uhler & Herbert, 1983) multiple copies of similar peptides, as in 
proenkephalin, or of the same peptide, for example in yeast pro a-mating factor 
(Kuijan & Herskowitz, 1982). In all cases, there is a striking similarity in that all the 
active peptide domains are flanked by basic amino acids. These are usually arranged 
as pairs, or less often as singlets, triplets or quadruplets (Rholam et al, 1986), and do 
not appear in the final hormone sequence.
Several putative processing enzymes have been studied that will cleave 
prohormones in vitro at these basic pairs. Cleavage has been observed on the amino 
terminal side of the doublet in the case of prosomatostatin (Gluschankof et al, 1985), 
between the pair in proenkephalin B (Mizuno et al, 1985) and yeast a-mating factor
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(Mizuno & Matsuo, 1984), and on the carboxyl side in POMC (Chang & Loh, 1983), 
prooxytocin (Clamagirand et al, 1986) and provasopressin (Parish et al, 1986). These 
basic amino acids appear to be the primary signal for endoproteolytic cleavage as 
there is no other consensus seen between prohormones at these regions. However, 
further examination of the structures of these peptides reveals additional basic amino 
acid pairs at sites that do not appear to be susceptible to proteolysis, for example 
within the sequences of growth hormone releasing factor (Gubler etal, 1983) and 
glucagon (Bell et al, 1983 and Lund et al, 1983). In a study using analogues of 
prooxytocin, it was demonstrated that cleavage could occur when the L y s^ -A rg ^  
doublet was reversed, but not when either was replaced by its D-isomer or by a 
neutral amino acid (Nle); analogues which contained the native basic pair, but which 
had substitutions affecting the predicted secondary structure upstream of the doublet 
also abolished cleavage susceptibility (Cr6minon et al, 1988).
It is therefore apparent that although the basic pair is an essential signal for 
endoprotease cleavage, there must be additional information within the precursor 
molecule that directs endoproteolysis only to appropriate basic pairs. Calculation of 
the predicted structures around such cleavage sites of twenty prohormones (using the 
prediction method of Chou & Fasman, 1978) revealed that such sites are always 
found within or immediately adjacent to regions with high p-tum formation 
probability; the sequences on either side of these regions have high probabilities for 
forming highly ordered structures, i.e. a-helix or p-sheet (Rholam et al, 1986). These 
properties are well illustrated by prooxytocin, which is cleaved on the carboxyl side 
of the dibasic pair L ys^-A rg^ . Predictions suggest that residues 8 to 12 form a p- 
tum typical of a region subject to endoprotease attack, while the flanking sequences
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are ordered: residues 1 to 7 forming a (3-sheet and 13 to 21 an a-helix (Creminon et 
a l  1988).
A more recent study of predicted prohormone structure near to endoproteolytic 
cleavage sites, which included the newly defined structural feature, the Q. loop, found 
that of the potential sites studied, 25% occur in P-tums, 32% in Q loops and 42% in 
a-helices (Bek & Berry, 1990).
Following the action of an endoprotease cleaving on the carboxyl side of a 
dibasic pair, as for prooxytocin, the signalling amino acids are removed sequentially 
by an enzyme specific for carboxy terminal basic amino acids. Because of its 
specificity, this activity was initially termed "carboxypeptidase B-like", but it has 
since been shown to be more highly specific for basic residues than is 
carboxypeptidase B (CPB), and to differ in certain properties (Fricker, 1988a).
The presence of a carboxy terminal a-amide group is seen in about half of all 
neuropeptides and peptide hormones; in the majority of cases this amide group can be 
shown to be essential to activity (Eipper & Mains, 1988). An assay for the a-amide 
moiety has been used to identify novel bioactive peptides, and has also revealed that 
such amidated peptides are only present in neural and endocrine tissues (Tatemoto & 
Mutt, 1978 and Tatemoto et a l  1986). These peptides have also been discovered in 
relatively primitive animals such as the sea anemone (Grimmelikhuijzen & Graff, 
1986) and locust (Proux et a l  1987), suggesting that they are an ancient phenomenon.
All carboxy terminally amidated peptides are initially synthesized within 
precursor molecules, and sequencing has revealed that the carboxy terminal amino 
acid of the final peptide sequence is always followed in the precursor by a glycine 
residue. This glycine is targeted by an enzyme and donates the nitrogen from its a-
23
amino group to form the carboxy terminal a-amide in the active peptide; thus the 
inactive sequence -X-Gly is transformed to the active -X-NH2  and the residual 
glycine is released as glyoxylic acid (Bradbury et al, 1982). The enzyme activity that 
catalyses this reaction can only occur after both the endoprotease and the 
carboxypeptidase activities have released the peptide sequence from the precursor 
and removed the extra basic amino acids to leave glycine as the carboxy terminal 
residue (Bleakman & Smyth, 1987).
1.2.2. Processing Enzymes for Oxytocin and Vasopressin
When trying to identify an enzyme involved in the processing of a precursor 
such as prooxytocin, it is important to know the intracellular site of activity. The 
hypothalamic oxytocin precursor is transported along the axon of the secretory 
neurone down the pituitary stalk and into the neural lobe of the pituitary; processing 
occurs during this axonal transport and within the axon terminals where the products 
of processing are stored (Brownstein et al, 1980). As all of the protein transported 
from the hypothalamus to the neural lobe is contained within secretory granules, it 
was concluded that axonal processing was taking place within these neurosecretory 
granules (Brownstein et al, 1980). Pulse-chase labelling experiments, originally used 
by Palade in studies on the pathway of protein secretion (Palade, 1975), provided 
additional evidence that processing could only occur once the precursor had been 
translocated across the Golgi and packaged into neurosecretory granules (Gainer et 
al, 1982).
The overall picture of oxytocin and vasopressin biosynthesis in the 
hypothalamo-neurohypophyseal system is, therefore, as follows: gene transcription
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and RNA splicing occur within the nuclei of the magnocellular neurons of the 
supraoptic, suprachiasmatic and paraventricular nuclei. Translation of the mRNA on 
the rough ER results in translocation of the nascent protein into the lumen of the ER 
and removal of the signal peptide. The prohormone then travels to the Golgi, and 
emerges from there packed inside a neurosecretory granule with the components 
necessary for its conversion to active products during axonal transport to the neural 
lobe (or any alternative destination). If axonal transport is artificially blocked by the 
use of colchicine, granules accumulate in the cell bodies but processing proceeds at a 
normal rate (Birkett et al, 1983); this demonstrates that the granule is acting as a 
discrete environment providing everything needed for complete processing of the 
precursors, independent of its location along the hypothalamo-neurohypophyseal 
tract.
In order to identify an enzyme studied in vitro as one involved in precursor 
processing in vivo, Docherty and Steiner (1982) proposed criteria specifically for 
proteases, but which can be adapted to include all the processing enzymes. As well 
as being present in the correct location, in this case the neurosecretory granules of the 
hypothalamo-neurohypophyseal system, the enzyme must be able to act on the 
natural substrate to produce all known products. The enzyme should be purified of 
all similar, contaminating activities and biochemically characterized to assess 
whether it would be active under the conditions found at the in vivo site of processing 
(e.g. pH optimum and cofactor requirements). Conclusive evidence of participation 
in prohormone maturation requires demonstration that specific inhibition of the 
enzyme by a suitable method can prevent normal processing from occurring in vivo.
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There are three enzyme activities involved in processing prooxytocin or 
provasopressin within the secretory granule (see figure 1.7). Endoproteolytic 
cleavage occurs in both prohormones between A rg ^  and A la ^  to release the amino 
terminal hormone domain with the Gly-Lys-Arg extension, and between A rg^S and 
Aia109 in provasopressin only to separate the neurophysin and glycopeptide domains. 
The first of these steps occurs after a typical basic pair, L ys^-A rg^ , which as stated 
earlier is probably at a (3-turn. The second site of endoproteolysis, however, has only 
the single basic A r g ^ ,  and is not always observed; sequencing of a frog 
neurophysin revealed that cleavage had not occurred between the neurophysin and 
glycopeptide domains, and the molecule remained intact as "big" neurophysin 
(Michel et al, 1987); this has also been demonstrated in the green turtle (Licht et aly 
1984).
The basic amino acids that signalled endoproteolysis are then trimmed by an 
enzyme or enzymes specific for carboxy terminal basic residues. This involves 
Argl^ and Lys* * of both extended hormone sequences, as well as the extra residue at 
the carboxy terminus of neurophysin from prooxytocin (His ^ 6  or A rg^^) or 
ArglOS from provasopressin. The neurophysins and glycopeptide are now in their 
mature forms, but the hormone sequences are still extended by G ly^ , which is acted 
upon by another enzyme to leave the active carboxy terminally amidated oxytocin or 
vasopressin. While this scheme of processing has been assumed for many years to be 
the correct one, there is now much evidence to support it in the form of identification 
of the various predicted intermediate forms in secretory granule preparations 
(Clamagirand et al, 1987a) and tissue sections (Altstein et aly 1988), as well as
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isolation of appropriate enzyme activities from various tissue preparations (see 
below).
1.2.3. Endoprotease Activity
Early investigations of endoproteolytic enzymes in neurosecretory granules 
utilized in vitro cleavage of POMC to ACTH and P-endorphin (Chang et al, 1982); 
this study revealed the presence of an acid-thiol protease which was specific for pairs 
of basic amino acids, in granules from bovine neural lobes. Further studies with 
similar granule preparations used substrates of synthetic prooxytocin 
(Clamagirand et al, 1986) and cancer cell-derived human provasopressin (Parish et 
al, 1986), and both identified proteolytic enzymes cleaving between A rg ^  and 
Ala^3. The former report was of a 58kd molecule that was not a serine protease, 
while the latter described a 70kd glycoprotein with aspartyl protease activity that did 
not appear to cleave provasopressin at the single Arg residue between neurophysin 
and the glycopeptide. The 58kd enzyme has since been further characterized, using a 
prooxytocin 1"^^ peptide substrate, as a thiol-metalloprotease with an optimum pH 
around 7.0; it is specific for the basic pair, but will also cleave when Lys* 1-Argl^ is 
reversed to Arg* 1-Lys^ (Clamagirand et al, 1987a). Although essential for 
cleavage, the dibasic pair alone is not a sufficient feature for recognition by this 
endoprotease; a minimum substrate length of nine residues, either 7-15 or 8-16, is 
necessary, and the structural nature of the regions immediately flanking the dibasic 
pair also influences enzyme activity (Brakch et al, 1989). A similar enzyme has also 
been found in secretory granules from bovine corpus luteum, with a size of 52-58kd 
and similar specificity and thiol-metalloprotease activity (Clamagirand et al, 1987b).
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It differs, however, in its acidic nature (pi 4.9 compared with 6.9/7.1 for the neural
There are thus two proteases reported in bovine neurosecretory granules that 
both cleave suitable substrates in vitro to give the expected products, but they have 
different sizes (70kd and 58kd) and widely differing characteristics. Both enzymes 
are found at the correct intracellular site for processing, and both generate the 
predicted products in vitro. However, only the 70kd enzyme has a pH optimum 
appropriate for the acidic nature of the neurosecretory granule.
To date, no cleavage between neurophysin and glycopeptide has been 
demonstrated in vitro. The inabilities of the 58kd enzyme to cleave at single basic 
residues within a peptide (Clamagirand et ah 1986) and of the 70kd enzyme to cleave 
provasopressin at A r g ^ ,  together with the absence of cleavage at this position in 
frog provasopressin (Michel et al, 1987), suggests that this activity is due to a 
different enzyme in vivo, which has not yet been isolated from neural lobe extracts. 
An enzyme thought to be involved in the processing of enkephalins has been found in 
chromaffin granules which cleaves a model substrate at a single Arg residue; it is a 
thiol metalloprotease of about 45kd, with a pH optimum of 7.8 but still active at pH 
6.0 (Tezapsidis & Parish, 1989). A related enzyme may exist in neurosecretory 
granules to process provasopressin, however the pH profile does not support its 
function in acidic granules, and it would be expected to occur in granule preparations 
that exibit activities of other processing enzymes.
A different approach to the identification of a mammalian prohormone- 
processing endoprotease has been taken by searching for a gene sequence related to
enzyme) and kinetic properties towards the prooxytocin substrate (Plevrakis et
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that of a yeast enzyme with appropriate endoproteolytic activity. The enzyme Kex2 
is a calcium-dependent, neutral serine protease which cleaves pro-peptides at pairs of 
basic amino acid residues; it is a product of the KEX2 gene in Saccharomyces 
cerevisiae (Fuller et al, 1989a). The enzyme is heavily glycosylated and is anchored 
into the membrane by a hydrophobic region near the carboxy terminus; the remaining 
part of the protein protrudes into the cytoplasm and is believed to be important in 
directing the enzyme to its functional location in late Golgi vesicles (Fuller et al, 
1989b). Kex2 can correctly process human proinsulin that is expressed in yeast cells 
(Thim et al, 1986), will cleave POMC when KEX2 is expressed in processing- 
deficient mouse cells (Thomas etal, 1988b) and membrane preparations with Kex2 
activity can process human proalbumin (Bathurst et al, 1987). It was therefore 
anticipated that the corresponding mammalian endoprotease(s) would have similar 
structural features to Kex2, and a database search revealed a human gene, fur, which 
showed partial sequence homology to KEX2 (Fuller et al, 1989b). The product of 
this gene, furin, displays 50% identity with the catalytic domain of Kex2; it also has a 
potential transmembrane region followed by a hydrophilic and highly charged tail, as 
does the yeast enzyme (Fuller et al, 1989b). It therefore appears likely that furin is a 
mammalian prohormone-processing endoprotease, although the ability of this protein 
to function as a protease has not yet been demonstrated.
1.2.4. Carboxypeptidase Activity
Studies on various neural and endocrine tissues, using substrates related to 
many different neuropeptides and peptide hormones, have revealed the association of 
a single carboxypeptidase enzyme with the processing of this family of molecules
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(for review see Flicker, 1988a); it has been designated EC 3.4.17.10 and is widely 
known as carboxypeptidase E (CPE), also as enkephalin convertase or 
carboxypeptidase H. Originally described as having CPB-like activity, it is in fact 
much more highly specific for basic amino acids than is CPB, which shows moderate 
affinity for some other residues.
As with the endoprotease, initial studies on carboxypeptidase activity were not 
carried out on neurohypophyseal precursors, but in this case using carboxy terminally 
extended enkephalins as substrates, and enzyme preparations from bovine adrenal 
chromaffin granules (Flicker & Snyder, 1982 and Hook et al, 1982). These and 
further studies characterized the enzyme as an acid thiol protease, maximally active at 
pH 5-6 and stimulated by cobalt ions, and strongly inhibited by 
guanidinoethylmercaptosuccinic acid (GEMSA), a site-directed inhibitor (Flicker et 
al, 1983, Flicker & Snyder, 1983 and Hook & Eiden, 1984). These properties can be 
used to distinguish CPE from the other known carboxypeptidases. Investigation of 
other tissues revealed the presence of similar activities in insulin secretory granules 
(Docherty & Hutton, 1983), hypothalamus, hippocampus, striatum, thalamus and mid 
brain, with highest activity in the pituitary (Fricker et al, 1982). The pituitary activity 
was further characterized (Hook & Loh, 1984), and found to be similar in all three 
lobes; moreover incubation of neural lobe granule lysate with vasopressin-Gly-Lys- 
Arg resulted in the appearance of the expected products, vasopressin-Gly-Lys and 
vasopressin-Gly (Hook & Loh, 1984). Extracts of bovine neurosecretory granules 
have also been shown to convert oxytocin-Gly-Lys-Arg to its corresponding products 
(Kanmera & Chaiken, 1985a and Clamagirand et al, 1986).
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CPE is found in both membrane-bound and soluble forms in bovine adrenal 
medulla, brain and pituitary, with identical physical properties in all the tissues, 
including molecular weights of 52-53kd for the membrane-bound and 50kd for the 
soluble form (Flicker & Snyder, 1983 and Supattapone et al, 1984). Evidence that 
there is a single enzyme providing activities in all these tissues is provided by these 
common sizes, identical characteristics of pH optimum, stimulation and inhibition, as 
well as similarity of kinetic parameters to a range of peptide substrates (Flicker & 
Snyder, 1983).
Because of the apparently high affinity of GEMS A for CPE over other 
carboxypeptidases, [^HJGEMSA has been widely used to locate CPE in tissue studies 
(for review see Flicker, 1988a); however this specificity has recently been disputed 
because carboxypeptidase M (CPM) is also inhibited significantly by GEMSA at low 
pH (Deddish et al, 1989), so CPM could give false results when probing for CPE with 
GEMSA at a low pH. CPE has been demonstrated using this technique in a wide 
range of tissues that are involved in production of neuropeptides and peptide 
hormones, including brain, pituitary, salivary gland, lung, ileum, colon, heart, 
pancreas, testis and spleen (Fricker, 1988a). In many of these tissues, CPE is shown 
to be localized in cells producing such peptides.
Dehydration and rehydration of an animal cause depletion and restoration, 
respectively, of the numbers of [^H] GEMSA binding sites in the posterior pituitary; 
such changes are not seen in the other lobes of the pituitary nor in the hypothalamus 
(Strittmatter et al, 1985). This mirrors the depletion in pituitary levels of oxytocin 
and vasopressin caused by their release in response to dehydration, and strongly 
suggests colocalization of CPE with the hormones inside neurosecretory granules.
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The unaltered levels of CPE in the hypothalamus, however, suggest that CPE 
synthesis is not stimulated by dehydration in the way that prohormone production is.
It was noticed in a study of CPE in cultured medullary chromaffin cells that the 
ratio of CPE enzymic activity to CPE immunoreactivity differed between cellular 
extracts and secreted material; the activity was much lower in the cellular material 
(Hook & Eiden, 1985). This could be explained by the presence of a precursor to 
CPE, which is immunoreactive but enzymically inactive, found only inside the cell 
and not secreted. This idea is supported by DNA studies. Although a gene coding 
for CPE has not yet been isolated, cDNA studies have revealed some useful 
information about the enzyme. The first cDNA clone from a bovine pituitary cDNA 
library was incomplete, but provided information on a partial sequence for the 
enzyme, including several pairs of basic amino acids (Fricker et al, 1986). Protein 
sequencing of both the soluble and membrane-bound forms of CPE revealed a 
common amino terminus, and the sequence deduced from the cDNA contained a pair 
of basic amino acids 22 residues from the carboxy terminus; cleavage of the enzyme 
at this site would reduce its size by about 3kd, which could account for the difference 
between the membrane bound (52-53kd) and soluble (50kd) types (Fricker et al, 
1986). Later estimations of size using more rapid purification methods have re­
defined these values at 53-55kDa for the soluble and 55-58kDa for the membrane- 
bound forms (Laslop et al, 1986 and Fricker et al, 1990). Using the prediction 
method of Chou and Fasman, these workers calculated that the predicted structure of 
this 22 residue region is an a-helix, and although most of the amino acids are 
charged, there are three pairs of hydrophobic residues which would protrude from one
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side of the helix and possibly provide a means of interaction with the membrane of 
the secretory granule (Fricker et al, 1986).
Re-screening of the bovine cDNA library resulted in the isolation of a longer 
clone (Fricker, 1988b). Examination of this longer sequence suggested the presence 
of a signal peptide followed by a short "pro-peptide” that is not seen in the enzyme 
isolated from tissues. Immediately before the amino terminal sequence common to 
both forms of the enzyme are 5 adjacent Arg residues, which are a likely target for 
cleavage (Fricker, 1988b). As the intact "proenzyme" sequence has not been isolated, 
it is not known whether it has any enzyme activity. Southern blotting of bovine 
genomic DNA suggests the presence of only one gene for CPE, and this supports the 
evidence for a common enzyme in many different tissues (Fricker et al, 1986).
Recently, a full length cDNA clone has been isolated from cDNA libraries of 
both hippocampus and hypothalamus of rat (Fricker et al, 1989), and a shorter clone 
from libraries of rat insulinoma and thyroid carcinoma cell lines (Rodriguez et aly
1989); the protein sequences from these studies differ at only one residue. Northern 
blot analysis reveals corresponding mRNA of a constant size of about 2.1kb in rat 
cerebellum, cortex, hippocampus, hypothalamus, midbrain, brainstem and striatum, 
as well as heart, adrenal, testis and duodenum (Fricker et al, 1989); CPE mRNA 
could not be detected in rat liver, despite reported GEMSA binding in this tissue 
(Lynch et al, 1987). cDNA for human CPE has also been prepared and indicates an 
mRNA transcript of 2.5kb leading to a proenzyme product of similar size and 
structure to those of both rat and bovine origin (Manser et al, 1990). Comparison of 
the sequences of rat and bovine CPE displays a high level of conservation: 91.6% 
homology for the entire preprotein (proCPE plus signal peptide) and 94.3% for the
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active enzyme sequences (Fricker et al, 1989). This is much higher than the level of 
homology between rat and bovine carboxypeptidase A (CPA) which is only 78% for 
the active region (Quinto et al, 1982).
The proteins with the highest homology with bovine CPE (discounting CPE 
from other species) are bovine CPB and bovine and rat CPA, and the residues thought 
to be important for activity in CPA and CPB are highly conserved in both bovine and 
rat CPE (Fricker et al, 1986 and Fricker et al, 1989). The major differences between 
the CPE sequences and those for CPA and CPB involve two internal regions of little 
homology and an additional 120 amino acids at the carboxy terminus of CPE; if the 
tertiary structure of CPE is similar to the other enzymes, the two additional internal 
regions in CPE would lie close to the substrate binding site, and so could account for 
the difference in substrate specificity of CPE (Fricker et al, 1986). The difference in 
pH optimum between CPE (5.6) and CPA/B (7.0) also has to be accounted for.
The sequences of CPA and CPB show 48% homology, compared with 20% for 
CPE and CPA, and 17% for CPE and CPB, suggesting that although CPE probably 
evolved originally from this digestive enzyme lineage, it was a considerable time 
before the divergence of CPA and CPB (Fricker et al, 1986). This is supported by the 
presence of very similar enzymes in frog, shark and Aplysia neural tissues; although 
the amino acid sequences are not yet known, most of the physical and enzymatic 
properties of CPE from these species are identical to the mammalian enzyme (Fricker 
& Herbert, 1988).
Further work on the membrane-bound form of CPE has shown that association 
with the membrane leads to reduced enzyme activity (at least against short, synthetic 
substrates) and that activity is increased when membranes are treated either with
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detergent or high pH buffers to solubilize the enzyme (Fricker, 1988c). The 
dependence of CPE-membrane association on pH is interesting; all the CPE activity 
in preparations of bovine pituitary membranes remained bound at pH values below 6, 
but the majority was solubilized by extraction with buffers above pH 8 (Fricker, 
1988c). Similar results have been presented on CPE from pancreatic islets of the 
anglerfish (Mackin & Noe, 1987). These findings suggest that at the intragranular pH 
at which in vivo processing occurs, much of the carboxypeptidase activity will be at 
the membrane.
The mechanism by which CPE is held to the membrane has also been the 
subject of detailed study. Synthetic peptides 11-24 residues long and corresponding 
to the carboxy terminus of the enzyme have been examined for their abilities to bind 
to bovine pituitary membranes (Fricker et al, 1990). All of the peptides bound to 
membrane preparations and were released under similar conditions to the complete 
enzyme; the mechanisms involved included both hydrophobic and ionic interactions, 
supporting the theory that the extra carboxy terminal portion of the membrane- 
associated form of CPE is an amphiphilic a-helix (Fricker et al, 1990). However, an 
antise^a/iiised to the 24-residue carboxy terminal peptide was seen to cross-react with 
one of the soluble forms of the enzyme (Fricker et al, 1990), so it would seem that 
cleavage of the membrane-bound to the soluble form could not take place at the 
Arg413-Lys414 ^ a s ic  pair as previously suggested (Fricker et al, 1986), as this 
would result in removal of the entire 22-residue carboxy terminus.
The carboxypeptidase activity involved in producing oxytocin and vasopressin 
is thus almost certainly CPE. This enzyme acts on precursors of a wide range of 
hormones and neuropeptides to remove the basic amino acids left at the carboxy
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terminus after signalling for endoproteolytic cleavage. It is probably encoded by a 
single gene and is synthesized as a precursor with an amino terminal extension; this 
extension may be removed by the action of the same endoprotease that acts on the 
prohormone, as it is joined to the active enzyme sequence by five adjacent Arg 
residues in both the rat and bovine forms. The gene that codes for the CPE precursor 
is related to those for CPA and CPB. Little is known about the regulation of CPE 
synthesis and activity in vivo.
Single Arg residues are also removed from the carboxy terminus of 
neurophysins from human and rat prooxytocin and from provasopressin; this is 
presumably achieved by CPE. However, removal of the His residue from the carboxy 
terminus of neurophysin from bovine prooxytocin may be by a different enzyme.
CPE has been shown to remove carboxy terminal His from synthetic peptides, but 
this reaction is extremely slow - about 6,000 times slower than cleavage of Lys from 
a similar substrate under the experimental conditions chosen (Smyth et alt 1989).
The ability to remove a carboxy terminal His residue is also required in the 
processing of p-endorphin to forms that have been isolated from the CNS (Smyth et 
al, 1981). An enzyme has been isolated from bovine neurosecretory granules that 
will cleave the carboxy terminal His from prooxytocin as well as from a synthetic 
hexapeptide (Norenberg & Richter, 1988). It displays remarkably similar properties 
to CPE: a thiol protease, stimulated by Co^+ with a pH optimum of 5.0-5.5, but it 
differs from CPE in size, being only 45kd (Norenberg & Richter, 1988).
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1.2.5. Amidating Activity
Enzymes with the ability to convert a carboxy terminal Gly to a -CONH2  group 
have been isolated from a wide range of tissues and display similar properties (for 
review see Eipper & Mains, 1988). Most of the studies have used the synthetic 
substrate [^^I]-D-Tyr-Val-Gly in a simple assay of amidation that was first used to 
demonstrate such activity in porcine pituitary secretory granules (Bradbury et al, 
1982). The same method was then used to demonstrate activity in secretory granules 
of anterior, intermediate and neural lobes of rat pituitary, as well as bovine 
intermediate lobe (Eipper et al, 1983).
Amidating activity has now been well characterized in mammalian 
hypothalamus (Emeson, 1984), cerebrospinal fluid (Vaeroy etal, 1987), small 
intestine (Noguchi et al, 1988), spinal cord (Graham & Gallop, 1989), heart (Kojima 
et al, 1989) and medullary thyroid carcinoma cells (Gilligan et al, 1989), as well as 
pituitary and frog skin (see Eipper & Mains, 1988). The enzymes all exhibit common 
characteristics of stimulation by copper and ascorbate, a requirement for molecular 
oxygen, and a pH optimum usually in the range pH 6.5-8.0. The apparent molecular 
weights vary, however, between 26 and 92kd. The properties of the enzymes have 
led to designation of the collective name peptidyl-glycine a-amidating 
monooxygenase (PAM).
PAM is found in tissues associated with oxytocin and vasopressin synthesis, i.e. 
neural lobe (Eipper et al, 1983) and corpus luteum (Sheldrick & Flint, 1989), and in 
both cases the enzyme is co-localized with the hormones in secretory granules. 
However, the pH inside neurosecretory granules is 5.8 (Russell & Holz, 1981 and 
Sherman & Nordmann, 1982), and the activity of the pituitary enzyme in vitro is
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maximal at pH 7.0, dropping sharply below pH 6.0 (Eipper et al, 1983). PAM has 
been shown to have the ability to convert oxytocin-Gly to mature oxytocin (Ando et 
al, 1988), but again only at a high pH, in this case pH 8.5.
1.2.6. Problems Remaining in Understanding Oxytocin and Vasopressin 
Production
When trying to identify and characterize a prohormone processing enzyme, the 
criteria of Docherty and Steiner, detailed earlier, must be kept in mind. The use of 
small, synthetic peptide substrates can be useful for the initial localization of a 
particular enzyme activity, but that enzyme must be shown to have sufficient activity 
on the natural substrate under conditions as close as possible to those found in vivo. 
Detailed studies of enzyme characteristics are often based on model substrates and 
conditions decided entirely by achieving maximal activity, rather than considering the 
environment in which the enzyme is acting in the cell. This is particularly apparent in 
the case of the amidating enzyme, where technical problems make it difficult to study 
amidation of natural substrates, and a wide range of cofactors are used often without 
consideration of their presence or otherwise at the in vivo site of activity. The only 
study using oxytocin-Gly as substrate still involved the use of a pH optimal for in 
vitro enzyme activity rather than the acidic pH of the neurosecretory granule (Ando et 
al, 1988), so the relevance of the findings of such studies to the in vivo situation must 
be questioned.
The initial consideration when studying the processing of prooxytocin, then, is 
the form of the substrate for each processing enzyme. Most evidence presented so far 
points to the scheme outlined in figure 1.7; the endoprotease enzymes act on
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prooxytocin, the carboxypeptidase on oxytocin-Gly-Lys-Arg and oxytocin-Gly-Lys, 
and the amidating enzyme on oxytocin-Gly. However, the presence of the 
neurophysin sequence in the prohormone, and its affinity for oxytocin, must be 
considered. In a study using a semi-synthetic prohormone, the hormone sequence 
was shown to be already associated with the hormone binding site on the neurophysin 
moiety before endoproteolytic cleavage (Kanmera & Chaiken, 1985b), so this is 
likely to be the initial substrate for processing. Neurophysin has been shown by 
affinity chromatography studies to bind oxytocin-Gly-Lys-Arg in a similar manner to 
oxytocin at pH 5.7 (Kanmera & Chaiken, 1985a), so it can be assumed that after 
initial endoproteolytic cleavage, the extended hormone and the neurophysin 
sequences remain bound, and this complex is in fact the substrate seen by both 
carboxypeptidase and amidating enzymes. Working on these assumptions, studies 
have been carried out on the ability of enzymes from neurosecretory granules to 
process oxytocin-Gly-Lys-Arg and oxytocin-Gly in the presence of neurophysin 
(Kanmera & Chaiken, 1985a and Ando et al, 1988). Both of these studies reported 
slightly increased carboxypeptidase activity in the presence of neurophysin equimolar 
to the substrate, but decreased activity at higher neurophysin concentrations; the later 
study showed similar effects on amidation. The rate enhancing effect was also 
achieved with a protein of similar size to neurophysin, so the effect of neurophysin 
was described as being non-specific (Ando et al, 1988). The inhibition of activities 
by high concentrations of neurophysin was thought to be due to stearic constraints on 
processing due to association of neurophysin-hormone complexes with additional 
neurophysin. However, the situation in vivo will not allow any excess of neurophysin
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over hormone as they are produced in equal amounts from the same precursor, so 
again the validity of comparing these results to the in vivo situation appears flawed.
The in vivo site of processing, the intra-granular environment, has been studied 
with respect to pH (Russell & Holz, 1981) protein concentration (Nordmann & 
Morris, 1984), and ascorbate and metal ion content (Thom et al, 1986). These reports 
have built the picture of an acidic environment, with extremely high concentrations of 
hormone precursor and cleaved products (0.06M), such that a large proportion of the 
complex may be in crystalline form and there is very little volume remaining in the 
granule for accomodation of other molecules (Nordmann & Morris, 1984). The 
relatively high ascorbate level (45 to 60nmol/mg protein) provides a reducing 
environment, sustained by electron transport across the granule membrane (Russell et 
al, 1985). This transport is thought to be mediated by cytochrome b ^ i  in both the 
neurosecretory granule (Russell et al, 1985) and the adrenal chomaffin granule (Njus 
et al, 1983), where the ascorbic acid may act as an electron donor to the amidating 
enzyme.
Measurement of metal ions in neurosecretory granules resulted in no detection 
of cobalt (<5pmol/mg protein), but fairly high levels of both copper and zinc (Thom 
et al, 1986). If the total contents of these metals were in soluble forms, the 
concentrations would be considerably higher than in plasma, and the copper would be 
far in excess of the level required for maximal activity of the amidating enzyme; 
however, both metals are shown to be largely associated with the membrane fraction 
of granule preparations, presumably bound to proteins, perhaps copper to the 
amidating enzyme and zinc to CPE (Thom et al, 1986).
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Another environmental effect on the enzymes in vivo that has not been widely 
considered is the entrapment by, and therefore proximity to the granule membrane.
All three types of processing activity necessary for maturation of oxytocin and 
vasopressin have been isolated as forms with either a membrane spanning region or 
part of the enzyme in close association with the membrane, yet nearly all enzyme 
studies are carried out in aqueous solution in the absence of any lipid component. 
Granules from rat anterior pituitary contain comparable amounts of soluble and 
membrane bound endoprotease activity (Chang & Loh, 1983); similar activity 
purified from bovine neurohypophysis and corpus luteum is found in two isoforms, 
possibly a membrane-bound enzyme and a smaller, soluble molecule formed by 
processing of the larger form (Plevrakis et al, 1989). As detailed in the above section 
on CPE, this enzyme has also been found to be associated with the granule 
membrane. Studies on the relative activities of the soluble and membrane-bound 
forms suggest that the soluble enzyme has a higher specific activity (Hook, 1985 and 
Flicker, 1988b); however these studies used unnatural substrate molecules: 
respectively iodinated Met-enkephalin and a short synthetic tripeptide. The 
amidating enzyme is commonly found in several different forms within the same 
tissue, including some on the membrane, and many of these are believed to be bound 
by a membrane spanning region; for example in frog skin (Ohsuye et al, 1988), 
mammalian heart (Kojima et al, 1989, Eipper et al, 1988 and Stoffers et al, 1989), 
and bovine pituitary (Eipper et al, 1987, and May et al, 1988). These enzyme studies, 
taken together with the finding of copper, a cofactor for the amidating enzyme, and 
zinc, a cofactor for CPE, mostly in the membrane fraction, strongly suggest that the 
inner surface of the granule membrane may be a site of processing activity.
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If it is accepted that all the processing enzymes may be active at the membrane 
surface, the problem remaining is the location of the peptide substrates. Newly 
synthesized POMC has been found to be largely associated with the granule 
membranes of both frog and mouse intermediate lobe cells (Loh & Tam, 1985). 
Neurophysin has also been shown to associate with membrane lipids (Audhya & 
Walter, 1979) and has been isolated from neurosecretory granule membrane 
preparations (Swann & Pickering, 1976); this introduces the possibility of a 
mechanism by which the immature hormone substrates, bound to neurophysin, could 
be held close to the granule membrane where the processing enzymes could 
effectively exist as a multi-enzyme complex with their metal ion cofactors. The 
chemical environment adjacent to the membrane will differ considerably from the 
typical aqueous solution used in most enzyme studies and could possibly allow for 
activity of all the required enzymes under identical conditions, which has never been 
achieved in an in vitro study.
Another problem which has not been addressed is the slow removal of carboxy 
terminal lysine residues from substrates by CPE. If the assumption that CPE is the 
only carboxypeptidase involved in prohormone processing (Fricker et al, 1989) is 
correct, it appears puzzling that the enzyme is far more efficient in cleavage of 
arginine than of lysine. Perhaps under different conditions, both residues could be 
cleaved with equal efficiency.
Full understanding of processing of the oxytocin precursor therefore appears to 
be restricted by the lack of consideration for the granular environment where the 
reactions are taking place. A more integrated approach involving the use of native 
substrates, all of the processing enzymes and conditions approaching those found in
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vivo may serve to overcome some of the remaining gaps in the knowledge of this 
system - including the apparent incompatability of isolated enzymes (in terms of pH 
and cofactor requirements) and the low rates of cleavage observed with lysyl 
substrates. The aims of this study, therefore, are to examine the effects of some of 
the factors discussed here on the activities of the processing enzymes. Those factors 
include substrate form and chemical environment, including protein concentration 
and the presence of neurophysin, and the influence of membrane components, with 
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Figure 1.2. The hypothalamo-neurohypophyseal system. OC, optic 
chiasma, PVN, paraventricular nucleus, SCN, suprachiasmatic nucleus, SON, 
supraoptic nucleus, ME, median eminence, P, posterior pituitary, I, intermediate 
pituitary, A, anterior pituitary.
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Vasopressin Neurophysin II Glycopeptide
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Figure 1.3. Structural organization of the genes coding for 
preprovasopressin and preprooxytocin. Exon A of both genes codes for 19 amino 
acids that comprise the signal peptide, as well as the hormone sequence itself, 3 
separating amino acids and the 9 amino terminal residues of neurophysin. Exon B 
codes for the central part of neurophysin. Exon C codes for the carboxyl end of 
neurophysin plus a single amino acid in preprooxytocin, or a 39-residue glycoprotein 
in provasopressin.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Bovine (VP) Ala-Met-Ser-Asp-Leu-Glu-Leu-Arg-Gln-Cys-Leu-Pro-Cys-Gly-Pro-Gly
Guinea pig ( V P )  Leu-----------T h r --------------------------------------------------------
Bovine (OT)  Val-Leu----------- A sp-Val------T h r -----------------------------------
Human (OT)  Ala-Pro----------- Asp-Val------L y s -----------------------------------
Bufo toad (VT) Ser-Tyr-Pro Thr-Ala-Val---------------- H e -------------------------
Sucker fish (VT)Ser-Gln-Pro Thr-[ ]-Ser G l u  Val-Ser --------------------
17 18 19 20 21 22 23  24 25 26 27 28 29  30 31  32 33  34 35  36
Gly-Lys-Gly-Arg-Cys-Phe-Gly-Pro-Ser-Ile-Cys-Cys-Gly-Asp-Glu-Leu-Gly-Cys-Phe-Val 
 G i n ----------------------------------------------------A l a  A l a -------------------------
---------------------------------------- As n ---------------- Ala-Glu------------------------------
Asn-Arg------ As n-------------------- A s n --------------------- G l u - A s p ---------------- T y r -----
A sn-Ala-----------------Tyr ----------------------------------- Ala-A la---------------- L e u -----
37  38  39 40  41  42  43  44  45 46  47  48  49  50 51 52 53  54 55  56
Gly-Thr-Ala-Glu-Ala-Leu-Arg-Cys-Gln-Glu-Glu-Asn-Tyr-Leu-Pro-Ser-Pro-Cys-Gln-Ser
--------- P r o ------ T h r ---------------- V a l----------- T h r --------------------------------Glu-Ala
 Ser-Pro Thr-Met-Ser M e t ----------------His ---------------------------Glu-Thr
57 58 59  60  61 62 63  64  65 66 67 68 69 70  71 72 73  74 75 76
Gly-Gln-Lys-Pro-Cys-Gly-Ser-Gly-Gly-Arg-Cys-Ala-Ala-Ala-Gly-Ile-Cys-Cys-Asn-Asp
------------------------------------------------------------------A s n ------ V a l --------------------
--------------------------------------------------------------------------------------------Ser-Pro
---------------A l a ------------------------------------------V al-Leu------ L e u -----------Ser-Pro
 G l y ---------------- Ser-------------------------------------P r o ------ V a l -----------Ser-----
 G l y - A r g--------------- Asp- G l u -------------------------- P r o------Val---------- Asp-Ser
77 78 79  80  81 82 83  84 85  86 87 88 89 90  91  92  93  94 95
Glu-Ser-Cys-Val-Thr-Glu-Pro-Glu-Cys-Arg-Glu-Gly-Val-Gly-Phe-Pro-Arg-Arg-Val
-------------------- H e  Glu-Phe-H is-[ ]------ Pro----
Asp-Gly------ His-Glu-Asp------A l a -----Asp-Pro-Glu-Ala-Ala-------Ser-Gln
Asp-Gly------ His-Ala-Asp------A l a -----Asp-Ala-Glu-Ala-Thr-------Ser-Gln
Asp-Thr---------- Val-Asp-Ser-Ser------ Leu-Asp-Glu-Asp-Ser-Glu-Arg-----
Val--------------- Met-Asp-Ser----------- L e u  A s p  Arg-Ser-Asp-Gln-Ser-Glu-
Figure 1.4. Amino acid sequences of neurophysins from various species.
Standard three letter symbols are used for amino acid residues. Dashes show a 
residue identical to the corresponding one in the top (bovine) sequence; brackets 
indicate a gap introduced to optimise alignment. Sequences from precursors of 
vasopressin (VP), oxytocin (OT) and vasotocin (VT) are shown. References: bovine, 
guinea pig and human, Breslow & Burman (1990); toad, Nojiri et al (1987); sucker 






Figure 1.5. Disulphide pairing in bovine neurophysins forming two 
separate domains. From Burman etal (1989).
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Figure 1.7. Processing of prooxytocin and provasopressin to generate 
active hormones, neurophysins and glycopeptide. The major functional domains 
are separated by endoproteolysis, then the basic residues which signal that cleavage 

























Table 1.1. Sequences of the neurohypophyseal hormones.
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Prototherian mammals Oxytocin Arginine vasopressin
Eutherian mammals Oxytocin Arginine vasopressin
Metatherian mammals Oxytocin Arginine vasopressin 
Lysine vasopressin 
Phenypressin
Pig Oxytocin Lysine vasopressin
Table 1.2. The presence of neurohypophyseal hormones in vertebrates.
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CHAPTER 2:
PREPARATION AND METHOD DEVELOPMENT
2.1. Introduction
In order to study the effects of substrate form and environmental conditions on 
CPE activity, it was necessary to produce a preparation of the enzyme, appropriate 
peptide substrates, a means of separating and quantifying substrates and products, and 
to devise a suitable method to assay the enzyme activity.
The major requirement for the enzyme preparation was that it should be rich in 
CPE activity with minimal contamination from other carboxypeptidases. The starting 
material of choice was therefore the soluble fraction from a preparation of bovine 
neurosecretory granules, obtained by ultracentrifugation. Similar preparations have 
been used previously to study CPE activity (Hook & Loh, 1984, Kanmera & Chaiken, 
1985a, Ando et al, 1988 and Plevrakis et al, 1989). If the effects of adding 
neurophysin to the reaction are to be assessed, it is essential to remove this protein 
from the initial enzyme preparation, and gel filtration provided a simple means of 
achieving this aim. Finally, the preparation needed to be characterized in terms of 
type of activity, pH spectrum and effectors to confirm that it was in fact CPE activity 
that was being observed.
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Following the overwhelming majority of evidence that the initial fragment for 
CPE activity in this system is the extended hormone sequence oxytocin-Gly-Lys-Arg, 
this peptide was chosen for these investigations. Again, this peptide has been used in 
previous studies as a substrate for prohormone processing enzymes (Kanmera & 
Chaiken, 1985a, Clamagirand et al, 1987b and Ando et al, 1988). The most 
convenient method of preparation of such a molecule in appropriate quantities is 
solid-phase synthesis. To assess any effect of ionic binding between this substrate 
and neurophysin on CPE activity, a control substrate is required which should be as 
similar as possible to the original substrate, but unable to interact with neurophysin. 
Treatment of oxytocin-Gly-Lys-Arg with performic acid was chosen, to yield a 
peptide with minimal chemical differences from the original and which would 
hopefully remain a viable substrate for CPE, but not bind to neurophysin. A 
neurophysin affinity column was used as a simple and rapid means of observing 
interaction between neurophysin and the two forms of substrate.
In order to develop a method to separate the substrates and products involved in 
the study, a series of standards was required. These were prepared from the cyclic 
and oxidised forms of substrate by digestion with commercial enzymes. Separation 
by reverse-phase high performance liquid chromatography (RP-hplc) was selected for 
its abilities to resolve several peptides in a single sample, rapidly, consistently, in 
both analytical and preparative quantities with simple and sensitive detection of 
peptide. In establishing the assay method, the important criteria were considered to 
be consistency, speed, economical use of reagents and throughput of large numbers of 
samples (up to 120). As the substrates were expensive to synthesize but a relatively 
high concentration of substrate was preferred, the minimum quantity of peptide that
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could be reliably monitored and quantified in the separation system was used in the 
minimum practical volume, and quantities of all other reagents were adjusted as 
appropriate,
2.2. Materials and Methods
Unless stated otherwise, all reagents were analytical grade, purchased from 
BDH Chemicals Ltd., Poole, UK.
2.2.1. Enzyme preparation.
Soluble and membrane fractions of bovine neurosecretory granule preparations 
were kind gifts of Sonia Birkett and Professor Brian Pickering at the University of 
Bristol. The soluble fraction (8mg) was dissolved in 0.1M ammonium acetate pH
5.8, centrifuged in an MSE Micro Centaur (Fisons Scientific Equipment, Crawley, 
UK.) at 11,600 x g for 5min, and 500|il of the supernatant underlayed onto Sephadex- 
G50(80) (Pharmacia Fine Chemicals, Uppsala, Sweden; 1 x 30cm) equilibrated with 
the same buffer. Fractions of 0.5ml were collected at a flow rate of 12ml/h, then 
diluted to 1ml with buffer to allow the absorbance at 280nm to be measured. An 
aliquot (5|il) of each fraction was assayed for carboxypeptidase activity. The 
fractions high in activity were pooled and used as the "soluble enzyme preparation"; 
this was stored at -40°C.
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2.2.2. Synthesis of oxytocin-Gly-Lys-Arg.
Oxytocin-Gly-Lys-Arg (OT-GKR) was prepared by solid-phase synthesis using 
the Fmoc-Polyamide method in a CRB Pepsynthesiser II semi-automatic peptide 
synthesizer (Cambridge Research Biochemicals Ltd., Cambridge, UK). The peptide 
was assembled from the carboxy terminus using 9-fluorenylmethoxycarbonyl (f-moc) 
to protect the a-amino groups and other suitable protecting agents on the side groups 
of the amino acids: methoxytrimethylbenzenesulphonyl for arginine, 
butyloxycarbonyl for lysine, triphenylmethyl for cysteine and butyl for tyrosine. All 
amino acid reagents were purchased from CRB and used in four-fold excess. The 
carboxy terminal arginine was mixed with dicyclohexylcarbodiimide (Aldrich 
Chemicals, Poole, UK) in dichloromethane to produce the reactive symmetrical 
anhydride, and linked to Pepsyn KA polydimethylacrylamide resin (CRB) with the 
aid of 4-dimethylaminopyridine as a catalyst at a loading of 0.095meq/g. Subsequent 
couplings utilized o-pentafluorophenyl esters of protected amino acids and the 
catalyst 1-hydroxybenzotriazole (Aldrich); the f-moc linkage is base-labile and was 
cleaved by treatment with 20% piperidine in dimethylformamide. The extent of each 
coupling was tested on a small sample of washed resin by the Kaiser test (Kaiser et 
al, 1970), using ninhydrin which forms a blue/purple colour with free amino groups.
When the sequence was complete, overnight treatment with trifluoroacetic acid 
(TFA, Aldrich) was used to cleave the peptide from the resin and remove the 
protecting groups; in the presence of phenol to assist deprotection of arginine, and 
1,2-ethanedithiol (Sigma Chemical Co., Poole, UK) to prevent formation of 
intermolecular disulphide bonds. The resin was removed by filtration, and most of 
the TFA removed by rotary evaporation at room temperature. Water was then added
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to give a final peptide concentration of 1 mg/ml, and the phenol and ethanedithiol 
removed by extraction into diethyl ether. The peptide solution was de-gassed with 
nitrogen and left open at room temperature to cyclise overnight. The peptide was 
lyophilized for storage at 4°C before purification by RP-hplc, using the peptide 
separation system detailed below. The peptide fraction from HPL^was desalted on 
a Sep-Pak C l8 cartridge (Waters Chromatography Div., Massachusetts, USA), eluted 
with 80% acetonitrile (ACN) in 0.1% TFA, lyophilized and stored at 4°C.
The expected amino acid content of the synthetic peptide was confirmed by 
amino acid analysis.
2.2.3. Preparation of standards oxytocin-Gly-Lys and oxytocin-GIy.
These methods were adapted from Kanmera & Chaiken (1985a). Oxytocin- 
Gly-Lys (OT-GK) was prepared from lmg OT-GKR by digestion with 2 units of 
TPCK treated trypsin immobilized onto agarose (Sigma T4019) in 200(il 0.1M 
ammonium bicarbonate, pH 8.6, for 2h at 37°C. The enzyme was removed by 
centrifugation in an MSE Micro Centaur at 11,600 x g for 5min. lmg OT-GKR was 
also digested with 14 units of carboxypeptidase B type I-DFP (Sigma C7261) in 
200(_il 0.1M ammonium bicarbonate pH 8.3 for 30min at 37°C, to produce oxytocin- 
Gly (OT-G). Both peptides were purified by RP-hplc, desalted on a Sep-Pak C l8 
cartridge and lyophylized.
2.2.4. Performic acid oxidation of peptides.
Performic acid was prepared by mixing 0.1ml 30%v/v hydrogen peroxide with 
0.9ml 90%v/v formic acid and standing at room temperature for lh. The acid was
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then cooled on ice and added to the appropriate dry peptide (O.lml/mg) and the 
mixture left on ice for lh. The peptide was separated from the reaction mixture using 
a Sep-Pak C l8 cartridge, dried, then purified by RP-hplc, using the same conditions 
as for purification of the synthetic OT-GKR. Performic acid oxidises the cysteine 
residues to cysteic acid, irreversibly opening the ring formed by the disulphide 
bridge.
To assess binding to neurophysin of the cyclic and oxidised forms of OT-GKR, 
20|ig of each peptide, in 200|il 0.1M ammonium acetate, pH 5.8, were applied to an 
affinity column consisting of bovine neurophysin covalently linked to agarose (0.75 x 
5cm, prepared by Dr RW Swann using the method of Robinson & Walker, 1979).
The column was washed with 10ml acetate buffer, then eluted with 10ml 0.1M 
formic acid. Fractions of 1ml were collected, and elution of the peptides from the 
column was monitored by RP-hplc analysis of 500|il samples of each fraction.
The ability of oxidised OT-GKR to act as a substrate for the enzyme preparation 
was tested by substitution of this peptide for untreated OT-GKR in the standard 
assay.
2.2.5. Separation of peptide standards by RP-hplc.
A single RP-hplc method was developed to both purify and separate all of the 
synthetic peptides used in this study. The system comprised two Gilson model 302 
pumps, model 802 manometric module, model 231 sample injector and model 621 
data module (all from Gilson Medical Electronics, Villiers Le Bel, France), an ABI 
1000S Diode Array Detector (Applied Biosystems Inc., Cheshire, UK) controlled by
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Gilson 714 software installed on an Opus V personal computer which was also used 
to store and manipulate the data.
Separation was achieved on Spherisorb C l8 (0.46 x 20cm, HPLC Technology 
Ltd., Macclesfield, UK). Buffer A was 67mM o-phosphoric acid (Aristar) adjusted to 
pH 3.0 with triethanolamine; buffer B was 40% buffer A, 60% ACN (HPLC grade S, 
Rathbum Chemicals Ltd., Walkerbum, UK). The gradient used for separation was 
25% to 40% buffer B in 15min, followed by a 5min wash of 100% buffer B; the flow 
rate was lml/min.
2.2.6. Assay of carboxypeptidase activity.
Unless stated otherwise, assays were conducted in 0.1 M ammonium acetate, pH
5.8, with l-2|il of enzyme preparation and 50pM peptide substrate in a total volume 
of 30|il, and the reaction proceeded for lh at 37°C. All reagents were first dissolved 
in assay buffer, solutions were equilibrated at room temperature before being 
dispensed into 1.5ml polypropylene microcentrifuge tubes (Elkay Products Inc., 
Shrewsbury, MA., USA.), with a Microman l-25pl positive displacement pipette 
(Gilson). Reactions were started by the addition of enzyme preparation to the tubes 
at 15s intervals, vortex mixing for 5s and placing in a 37°C waterbath. The reaction 
was terminated by the addition of 200p,l 0.1M HC1 at the same time interval, again 
mixing for 5s, and 200|il of each sample were analysed by RP-hplc as described 
above. Details of the automatic hplc sample delivery are given in the Appendix.
Automatic peak detection and integration enabled quantification of remaining 
substrate and newly-formed product in each sample, and thus calculation of the 
percentage of substrate converted to product in the reaction time, which was used as a
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measure of enzyme activity. Three or four replicates were prepared for each 
treatment. To allow statistical analysis to be performed, all individual percentage 
results were subjected to arcsin transformation, then results displayed as mean 
activity ± standard error of the mean (standard deviation/Vn).
2.3. Results
2.3.1. Separation of peptide standards by RP-hplc.
OT-GKR eluted at approximately 11.5min under the conditions used, while the 
linear, oxidised form eluted earlier at about 10.6min. The digestion products of OT- 
GKR, (OT-GK and OT-G) had progressively longer retention times, while the 
oxidised forms eluted earlier than the substrate peptide and in the reverse order 
(figure 2.1). Synthetic oxytocin (UCB Bioproducts SA, Braine L’Alleud, Belgium), 
which was used as a standard for quantitative estimation of peptides, co-eluted with 
OT-G at approximately 15.2min in this system.
2.3.2. Activity of the soluble enzyme preparation.
Gel filtration of the soluble fraction of bovine neurosecretory granules using 
Sephadex-G50 resulted in elution of a single peak of carboxypeptidase activity at the 
void volume of the column (figure 2.2). The six fractions with highest activity 
(numbers 19-24 inclusive) were pooled and the activity of this preparation assessed. 
The enzyme preparation was shown to cleave the carboxy terminal arginine from 
synthetic OT-GKR with an activity of approximately 560pmol/h/jil at pH 5.8, 37°C, 
in the presence of ImM cobalt chloride. This activity was optimal around pH 5.6
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(figure 2.3), was stimulated by cobalt and inhibited by copper, cadmium, p- 
chloromercuriphenyl-sulphonic acid (PCMPS) and ethylenediaminetetra-acetic acid 
(EDTA) (table 2.1). Suppression of CPE activity by guanidinoethylmercaptosuccinic 
acid (GEMS A, 1|J.M), resulted in a reduction of arginine cleavage activity to 16% of 
the control value.
2.3.3. Binding of cyclic and oxidised OT-GKR to agarose-linked bovine 
neurophysin.
At pH 5.8, all the untreated OT-GKR in the sample bound to the affinity column 
and was finally eluted with 0.1M formic acid; the oxidised peptide, however, was 
washed straight through the column without retardation (figure 2.4).
When both OT-GKR and oxidised OT-GKR were incubated with the enzyme 
preparation, the oxidised peptide was indeed found to act as a substrate, at least as 
effectively as did the cyclic form (figure 2.5); the relative cleavage efficiencies of 
these two substrates are considered in Chapter 4.
2.4. Discussion
The hplc separation system developed for this study allowed a single column 
and gradient combination to be used for all preparative and analytical procedures for 
the peptides involved. Use of the automatic sample injector and communication 
between the PC and the hplc modules allowed unattended analysis of up to eighty 
samples in each run, with a cycle time of 30min/sample.
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Complete resolution of all the substrates and products of the carboxypeptidase 
reaction made study of all relevant digestions possible. Co-elution of OT-G and 
oxytocin, however, remained an unresolved problem and prevented extension of the 
experimental work to the amidation reaction. This would have been an interesting 
addition to the study, but not possible without spending considerable time to establish 
another separation procedure.
Exclusion of the enzyme activity from Sephadex-G50 revealed the molecule(s) 
involved to have a molecular weight in excess of 30kD. The soluble enzyme 
preparation was shown to have significant activity in removal of the carboxy terminal 
arginine from OT-GKR; subsequent removal of the carboxy terminal lysine, however, 
was not observed. Although CPE is reported to exhibit lower affinity for carboxy 
terminal lysine residues than for arginine in the case of enkephalin precursors, this is 
only a twofold (Supattapone et al, 1984) or threefold (Flicker & Snyder, 1983 and 
Flicker & Herbert, 1988) difference. Removal of lysine from both vasopressin and 
oxytocin precursors by neurosecretory granule preparations has been reported (Hook 
& Loh, 1984, Kanmera & Chaiken, 1985a and Ando et al, 1988), albeit 7 times more 
slowly than removal of arginine in the case of extended oxytocin (Kanmera & 
Chaiken, 1985). However, despite using prepared OT-GK as the initial substrate, 
with increased quantities of enzyme preparation and extended incubation times, 
removal of lysine could not be achieved with this enzyme preparation.
Despite the problem of inactivity against lysine, the identity of the major 
carboxypeptidase activity in the preparation was confirmed as CPE by its pH profile 
as well as the effects of cobalt ions and various inhibitors. Comparison with previous 
studies of bovine pituitary preparations shows these results to be consistent with
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published findings. The pH optimum of 5.6 found here corresponds with reported 
values of 5.5-6.0 (Fricker & Snyder, 1982), 5.4-5.8 (Supattapone et al, 1984), 5-6 
(Kanmera & Chaiken, 1985a) and 5.6 (Fricker & Herbert, 1988).
CPE was originally identified as cobalt-stimulated activity at pH 5.6 (Fricker & 
Snyder, 1982 and Fricker et al, 1982), and the extent of stimulation of the bovine 
pituitary enzyme by cobalt ions has been reported to be between 2 and 12 times the 
activity in the absence of cobalt (Fricker et al, 1982, Supattapone et al, 1984 and 
Fricker & Herbert, 1988); in this study the addition of ImM cobalt chloride resulted 
in approximately 3.5 times the control activity.
Reduction of enzyme activity by EDTA, cadmium and copper ions to 18.5%, 
31.5% and <5% of control activity, respectively, is again consistent with published 
observations. Studies by Fricker et al (1982) and Supattapone et al (1984) on bovine 
pituitary preparations report inhibition by EDTA to 13% and 15%, by cadmium ions 
to 33% and 12% and by copper ions to 4% and 9% of control activities respectively. 
Carboxypeptidase activity was shown to be reduced to less than 5% by addition of 
ImM PCMPS both in this study and by Supattapone et al, (1984).
The definitive measure of CPE activity is now considered to be cobalt- 
stimulated carboxypeptidase activity at pH 5.6 which is abolished by low 
concentrations of GEMSA (Fricker & Herbert, 1988, Thiele & Fricker, 1988 and 
Vilijn et al, 1989). The activity of the preparation used for these experiments was 
reduced to 16% in the presence of IjiM GEMSA, so it was concluded from this and 
the above results that the major carboxypeptidase activity of this preparation was due 
to CPE.
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Neurophysin has been reported to possess similar affinities for oxytocin and the 
extended forms OT-GKR, OT-GK and OT-G (Kanmera & Chaiken, 1985a and Ando 
et aly 1988), so binding of OT-GKR to the neurophysin affinity column as described 
above was expected; as with neurophysin-oxytocin binding, the interaction between 
neurophysin and OT-GKR breaks down at low pH and so the peptide was eluted in 
formic acid. Oxidation of OT-GKR apparently abolished the interaction with 
neurophysin, as was hoped, and the peptide passed through the column without 
retardation. Performic acid treatment did not prevent the peptide from being cleaved 
by the enzyme preparation, however, so this substrate appeared to be a suitable 
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Figure 2.1. Separation of peptides by RP-hplc. Separation was achieved on 
Spherisorb C l8 (0.46 x 20cm, HPLC Technology) with a gradient of 15% 
acetonitrile, 85% TEAP (67mM triethanolamine phosphate, pH3.0) to 24% 
acetonitrile, 76% TEAP in 15min, at a flow rate of lml/min. Numbered peaks 
correspond to oxidised OT-G (1), oxidised OT-GK (2), oxidised OT-GKR (3), OT- 



























Figure 2.2. Gel filtration of bovine neurosecretory granule soluble fraction.
8mg of the soluble fraction from bovine neurosecretory granules were dissolved in 
600jil 0.1M ammonium acetate, pH 5.8, and centrifuged in an MSE Micro Centaur 
(Fisons) at 11,600 x g for 5min. 500|il of supernatant were underlayed onto 
Sephadex-G50(80) (Pharmacia, 1 x 30cm) equilibrated with acetate buffer. Fractions 
of 0.5ml were collected at a flow rate of 12ml/h and diluted to 1ml with buffer, 
protein content was monitored by measuring the absorbance at 280nm (open circles). 
A 5|il aliquot of each fraction was assayed for carboxypeptidase activity (solid 
circles) by incubation with 50|iM OT-GKR and ImM cobalt chloride in 0.1M 
ammonium acetate, pH 5.8, at 37°C for lh. The total incubation volume was 30|il. 
Reactions were terminated by the addition of 200|il 0.1M HC1, and samples analysed 












Figure 2.3. pH activity profile of the soluble enzyme preparation. 50pM 
OT-GKR was incubated with 3pl of enzyme preparation and ImM cobalt chloride, in 
0.1M ammonium acetate adjusted to the appropriate pH with acetic acid. The total 
incubation volume was 30|il and reactions proceeded for lh at 37°C, then were 
terminated by the addition of 200pl 0.1M HC1 and analysed by RP-hplc as described 
in the text. Individual values were subjected to arcsin transformation before 














Figure 2.4. Interaction of cyclic and oxidised forms of OT-GKR with 
agarose-neurophysin. 20jig each of cyclic and oxidised OT-GKR in 200|il 0.1M 
ammonium acetate, pH 5.8, were applied to a column (0.75 x 5cm) containing 
agarose-linked bovine neurophysin in the same buffer. The column was washed with 
10ml buffer then 10ml 0.1M formic acid to elute any ionically bound material. 
Fractions of 1ml were collected and 500|il of each fraction examined for peptide 














Figure 2.5. Cleavage of oxidised OT-GKR by the soluble enzyme 
preparation. 50pM OT-GKR (solid circles) and 50p.M oxidised OT-GKR (open 
circles) were incubated with 2.5|il enzyme preparation and ImM cobalt chloride in 
0.1M ammonium acetate, pH 5.8, in a total volume of 30}il. Reactions were 
terminated at the stated times by addition of 200|il 0.1M HC1 and samples analysed 
by RP-hplc as detailed in the text. Individual values were subjected to arcsin 
transformation before calculation of means and standard errors; n=4.
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Treatment % Control Activity
Cobalt chloride ImM 348
EDTA ImM 18.5
Cadmium chloride O.lmM 31.5
Copper chloride O.lmM <5.0
PCMPS ImM <5.0
Table 2.1. Characterization of carboxypeptidase £  activity of the 
soluble enzyme preparation. 50jiM  OT-GKR was incubated with 3pl enzyme 
preparation in 0.1M ammonium acetate, pH 5.8, in a total volume of 30pl at 37°C 
for lh. Reactions were terminated by the addition of 200}il 0.1M HC1, and 
samples analysed by RP-hplc as described in the text; n=4.
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CHAPTER 3:
THE EFFECTS OF NEUROPHYSIN AND PROTEIN 
CONCENTRATION ON CARBOXYPEPTIDASE E ACTIVITY
3.1. Introduction
As explained in Chapter 1, the initial in vivo substrate for CPE activity in 
oxytocin biosynthesis is probably an ionic complex of OT-GKR and neurophysin. 
Studies have shown that neurophysin can influence the in vitro processing rates of 
extended oxytocin intermediates by carboxypeptidase and amidating enzymes 
(Kanmera & Chaiken, 1985a, Ando et al, 1988). At a substrate concentration of 
710|iM, concentrations of 1420, 710 and 350|iM of neurophysin caused specific 
inhibition of carboxypeptidase activity, although processing still occurred at 50-70% 
of the control rate (Ando et al, 1988). Addition of a lower concentration of 
neurophysin (180p.M), however, resulted in a slight increase in carboxypeptidase 
activity, which was also observed when neurophysin was replaced by RNase S 
protein, which is similar in size to neurophysin, so the stimulatory effect of 
neurophysin on the enzyme was deemed to be non-specific. Similar stimulation of 
both carboxypeptidase and amidating activities was found using tenfold lower 
substrate and neurophysin concentrations of 71|iM; again these increases in 
processing rates could also be achieved with RNase S protein in the place of
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neurophysin. It was proposed that dimerisation of neurophysin-substrate complexes 
at the higher concentrations could impose stearic constraints on enzymic processing 
and thus act as a control mechanism to limit the production of active hormone; 
however the stimulation of the enzyme activities by neurophysin at lower substrate 
and protein concentrations was not persued.
Stimulation of catalytic activity by the addition of protein - the protein effect - 
has been demonstrated for the enzymes proline hydroxylase and tryptophan 
hydroxylase (Rhoads et al, 1967, Popenoe et al, 1969 and Rhoads & Udenfriend, 
1970), as well as phenylalanine hydroxylase (Guroff et al, 1970). In the case of 
proline hydroxylase, the increase in enzyme activity was shown to be related both to 
the sulphydryl content of the added protein, and to a factor that was acting in addition 
to the stimulation by thiol groups (Rhoads et al, 1967). In the study into the effects 
of neurophysin on processing enzymes, stimulation of activity was caused at low 
substrate concentrations both by neurophysin, which is rich in cysteine residues, and 
by RNase S protein, which has a significant sulphydryl content, when these proteins 
were added at the same concentration as the substrate (Ando et al, 1988). It seems 
possible, therefore, that neurophysin and RNase S protein were exerting their effects 
on the enzymes, at least in part, by a mechanism similar to that seen occurring with 
proline hydroxylase, that is, by a contribution from their sulphydryl groups. If the 
enzymes involved in biosynthesis of oxytocin are stimulated by sulphydryl groups, 
this may go some way to explaining the extraordinarily high cysteine content of 
neurophysin, the protein which is present during processing.
In view of the high protein concentration found within the neurosecretory 
granules the experiments described here were designed to investigate the effects of
72
neurophysin on CPE activity, specifically to examine the importance of neurophysin- 
substrate binding, and any general contribution to stimulation of the enzyme by 
protein molecules.
3.2. Materials and Methods
Preparation of the enzyme, peptide substrates and assay procedure are detailed 
in Chapter 2.
3.2.1. Preparation of OT-GKR affinity column.
The method of Robinson et al (1975) was used to covalently attach synthetic 
OT-GKR to CNBr-Sepharose 4B (Sigma). 45mg OT-GKR were reacted with 20ml 
67%v/v acetone at room temperature for 18h to protect the a-amino group of the 
peptide. The solution was rotary evaporated to dryness and the peptide redissolved in 
20ml reaction buffer (0.1M sodium carbonate in 0.5M sodium chloride, pH 8.5). 15g 
CNBr-Sepharose 4B was swollen in 100ml ImM HC1 for 15min, then washed on a 
glass sinter with 1000ml ImM HC1. Immediately before use, the gel was washed 
with 150ml reaction buffer, resuspended in 80ml buffer and added to the peptide 
solution. The suspension was mixed end-over-end for 3h at room temperature to 
allow the coupling reaction to take place. The gel was drained on a glass sinter and 
washed with 0.2M glycine in coupling buffer, pH 8.5, then mixed in 100ml of this 
solution for 2h to block any unreacted groups on the gel. After draining, the gel was 
washed alternately with 100ml each of coupling buffer and 0.1M sodium acetate in 
0.5M sodium chloride, pH 3.9, three times, to remove any adsorbed protein. The gel-
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peptide complex was then transferred to a glass column and washed with 0.5M acetic 
acid for 72h (12ml/h) to remove the acetone from the peptide. The column was 
stored at 4°C in 0.1M ammonium acetate, pH 5.8, containing 0.001% sodium azide 
as preservative.
3.2.2. Purification of bovine neurophysin.
Fresh bovine pituitaries were collected from Bath Wholesale Meats Ltd. (Bath, 
UK.) within 2h of slaughter and transported on ice to the laboratory, where the 
posterior lobes were dissected and extracted. Eight neural lobes were homogenized 
in 10 volumes (30ml) of 15%v/v TFA, 5%v/v formic acid and l%w/v NaCl in 1M 
HC1 (Bennett et al, 1978), using a Citenco homogenizer with a teflon pestle in a glass 
tube at speed setting 3.5, and protein was extracted into the acid preparation by 
mixing for lh at room temperature. The suspension was cleared by centrifugation at 
8,000 x g for lOmin at 4°C in an MSE High Speed 18 centrifuge (Fisons). The 
supernatant was desalted using a Sep-Pak C18 cartridge, the bound material eluted 
with 80% ACN/0.1% TFA and lyophilized.
This protein mixture was redissolved in 0.1M ammonium acetate, pH 5.8 
(0.5ml/neural lobe), centrifuged as above and the supernatant applied to the OT-GKR 
affinity column. After washing with 10 column volumes of acetate buffer, the bound 
material was eluted with the same volume of 0.1 M formic acid; 3ml fractions were 
collected at 12ml/h. The unbound and bound material in the fractions was detected 
by absorbance at 280nm and the appropriate fractions pooled into two peaks; these 
were desalted using a Sep-Pak C l8 cartridge, lyophilized, and stored at -40°C. 
Samples of extract before and after affinity purification were examined on
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polyacrylamide gels. Purity of the neurophysin preparation (bound peak) was 
confirmed by eluting as a single peak on hplc (using the standard RP-hplc method as 
described in Chapter 2).
3.2.3. Analysis of the affinity purification of neurophysin by 
polyacrylamide gel electrophoresis.
Pituitary extracts were analysed on a 7.5% mini-gel, with a 4% stacking gel and 
discontinuous buffer system (Davis, 1964). A 30% stock solution of monomer was 
prepared by dissolving 29.2g acrylamide (Bio-Rad Laboratories Inc., California,
USA) and 0.8g N,N-methylene bisacrylamide (Bio-Rad) in 100ml water; this was 
filtered and stored at 4°C in the dark. For the separating gel, 9.9ml water, 5ml 
monomer stock solution and 5ml 1.5M Tris-HCl, pH 8.8, were mixed and degassed 
for 15min. 100|il 10% ammonium persulphate and lOfil N,N,N',N'-tetramethyl- 
ethylenediamine (TEMED) were added and the solution mixed by gentle swirling.
The gel was poured into the gel plate assembly (Protean II Electrophoresis Cell, Bio- 
Rad) and overlayed with water. The stacking gel was prepared by mixing 6.2ml 
water, 1.3ml monomer stock solution and 2.5ml 0.5M Tris-HCl, pH 6.8, and again 
degassing for 15min. 50pl 10% ammonium persulphate and lOfil TEMED were 
added, the solution carefully mixed and poured onto the surface of the separating gel 
with the comb (which formed the sample wells) in place. The separating gel was 9cm 
wide, 7cm high and 0.1cm thick; the stacking gel measured 0.5cm from the base of 
the sample wells to the separating gel.
Two gels were inserted into the gel tank which was then charged with running 
buffer, containing 3g Tris, 14.4g glycine and lmg bromophenol blue per litre. The
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samples were dissolved in 50mM Tris-HCl pH 7.4 and applied to the gels. 
Electrophoresis was started at lOOv (Bio-Rad Model 2197 Electrofocusing Constant 
Power Supply) for 15min, to allow the samples to enter the stacking gel, then at 150v 
for 60min until the ion front (indicated by a line of bromophenol blue) approached 
the bottom of the gels. After disassembly of the apparatus, the gels were carefully 
removed from the plates and stained for 30min in 0.2% Coomassie brilliant blue,
10% glacial acetic acid and 30% propan-2-ol. Destaining was in 10% glacial acetic 
acid and 10% methanol overnight. The destained gels were photographed (plate 1) 
then dried with a vacuum gel drier (Bio-Rad).
3.3. Results
3.3.1. Stimulation of CPE activity by neurophysin.
Addition of bovine neurophysin caused a concentration-dependent increase in 
cleavage of arginine from OT-GKR by the enzyme preparation; this apparent dose 
effect was confirmed when a similar pattern was obtained using a higher enzyme 
concentration (figure 3.1). When neurophysin was added to incubations containing 
oxidised OT-GKR, activity against this substrate was also increased (figure 3.2). 
Conducting the assay in phosphate rather than acetate buffer did not alter the general 
effect of neurophysin on enzyme activity (figure 3.3).
3.3.2. The effect of protein on CPE.
Addition of BSA from 0.01 to 100 pM resulted in a quantitatively similar 
increase in activity against both forms of substrate (figure 3.4) to that seen on
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addition of 3 to 50|iM neurophysin. A selection of proteins was tested for their 
effects on activity and all were found to significantly increase cleavage of the cyclic 
substrate at a concentration of 2mg/ml (figure 3.5). The degree of stimulation caused 
by each protein, however, was unrelated to its cysteine content. Enzyme activity was 
equally stimulated by wheat germ agglutinin, which is cysteine-rich, and collagen, 
which has no sulphydryl residues; similarly, neurophysin, with 15% cysteine, caused 
approximately the same increase in conversion as did catalase, where cysteine is 
again absent.
As stimulation of enzyme activity appeared to be independent of the presence of 
sulphydryl groups in the proteins, the influence of hydrophobicity on CPE was 
examined. t-Butanol was added to the incubations, and again stimulation was 
observed in a concentration-dependent manner (figure 3.6).
3.3.3. Inhibition of CPE activity by neurophysin.
To examine the reported effects of high concentrations of neurophysin causing 
inhibition of CPE activity, experiments similar to those described in the published 
studies (Kanmera & Chaiken, 1985 and Ando et al, 1988) were conducted. At a 
concentration of 50pM OT-GKR, 50|iM neurophysin caused the expected increase in 
activity, as did RNase S protein (figure 3.7a). A higher concentration of either 
protein, however, led to a reduced level of stimulation (figure 3.7a). Activity against 
the oxidised substrate followed a similar pattern (figure 3.7b). When a higher 
concentration (500|iM) of OT-GKR was used, both neurophysin and RNase S protein 
at 50}iM caused an increase in activity; however when 500p,M protein was present,
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CPE activity was reduced to less than the control activity by both proteins (figure 
3.7c).
3.4. Discussion
The previously reported ability of neurophysin to stimulate CPE activity at low 
concentrations (Kanmera & Chaiken, 1985a and Ando et al, 1988) was confirmed by 
these experiments, as was the non-specific nature of the effect; similar increases in 
activity were obtained with all the proteins tested. The stimulation was also shown 
conclusively to be independent of any ability of neurophysin to bind the substrate, as 
similar profiles were obtained for untreated OT-GKR, which would be expected to 
interact with neurophysin under the assay conditions, and oxidised OT-GKR, which 
would not. Phosphate concentration has been reported (Tellam & Winzor, 1980) to 
influence the extent of neurophysin-hormone binding, but replacing the acetate assay 
buffer with a phosphate buffer had no apparent effect on stimulation of CPE activity 
by neurophysin. If the stimulation was related to ionic binding between neurophysin 
and the peptide substrate, a factor that altered the strength of this binding, such as 
phosphate concentration, would also be expected to affect the influence of 
neurophysin on the carboxypeptidase reaction. As no change in the effect of 
neurophysin was observed when phosphate was used, this provides more evidence 
that stimulation of CPE activity is not related to neurophysin-substrate binding.
The mechanism by which these proteins act to enhance CPE activity is unlikely 
to be related to thiol groups, as proteins lacking in cysteine residues (myoglobin, 
collagen and catalase) were seen to stimulate the enzyme to a similar extent as did
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those with substantial sulphydryl content (neurophysin and wheat germ agglutinin). 
Assays were also conducted in the presence of dithiothreitol (0.01 to O.lmM) and L- 
cysteine (ImM); this had no apparent effect on enzyme activity, so it would seem 
unlikely that protein could be enhancing catalysis by providing additional sulphydryl 
groups when a small, sulphydryl-containing molecule such as dithiothreitol was 
ineffective.
The peptidase activity of carboxypeptidase B has been shown to be stimulated 
by low concentrations of 1-butanol (0.03-0.3M), and to a lesser extent by 1-propanol, 
ethanol and methanol (Folk et al, 1962); the effect of butanol was thought to be due 
to reversible modification of structure at the active site. In the present study, addition 
of t-butanol to the incubations caused an increase in CPE activity. As proteins have a 
hydrophobic component, they may be acting on the enzyme by increasing the 
hydrophobic nature of the environment and causing the enzyme to adopt a more 
active conformation; many factors, such as small changes in pH or ionic 
concentration, or the presence of other molecules, can have subde effects on the 
tertiary structure of an enzyme, and small alterations of structure at the active site can 
have major effects on activity. Such a mechanism may be related to the high protein 
concentration found at the in vivO site of CPE activity, the neurosecretory granule, 
allowing maximum activity of processing enzymes.
Evidence to the contrary, however, comes from the observations of reduced 
CPE stimulation, and even inhibition, when high concentrations of protein were 
added. If the effects of protein seen in the last set of experiments were occurring in 
the granule, the extremely high levels of protein there would be expected to greatly 
reduce enzyme activity, so perhaps the effects of protein seen In^itr^ are not relevant
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to thein vivo^ituation. Inhibition of activity by high levels of protein could prove 
problematical when attempting to re-create an intragranular environment for(jn^vitro) 
study of the processing enzymes.
Reduced stimulation by a high concentration (500|iM) of neurophysin, and 
actual inhibition of activity when combined with a high substrate concentration, again 
confirmed earlier findings (Kanmera & Chaiken, 1985a and Ando et aly 1988). 
However, similar results were obtained both when neurophysin was replaced by 
RNase S protein, and when oxidised substrate was used. As there is no evidence to 
suggest interaction occurring between RNase S protein and either substrate, and the 
oxidised substrate has been shown not to bind to immobilized neurophysin (Chapter 
2), it appears that reduced stimulation or inhibition by high concentrations of 
neurophysin are unrelated to substrate-neurophysin binding. This contradicts the 
findings of the studies referred to above, where high levels of RNase S protein did not 
have the same effect in reducing CPE activity as did neurophysin, and inhibition was 
thought to be due to dimerisation of neurophysin-substrate complexes imposing 
stearic constraints on processing reactions (Ando et al, 1988). The precise 
mechanism whereby high concentrations of neurophysin inhibit processing must 
await further investigation but since this clearly is not related to neurophysin- 
substrate binding it might involve a direct interaction between neurophysin and the 
enzyme.
The question of high protein concentration within the granule may not be a 
problem for enzyme activity if this protein is not all in solution. The osmotic 
potential across the granule membrane would be considerable if all of the precursor 
protein was free in solution. Some mechanism must therefore exist to prevent the
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granule from swelling due to inflow of water. Microscopic studies have suggested 
that the intragranular contents (mainly precursor protein) are present in a semi- 
crystalline state (Nordmann & Morris, 1984); this would reduce the osmotic potential 
inside the granule (only molecules in solution can contribute to this effect), and 
would also solve the problem of inhibition of processing enzymes by very high 
protein concentrations, if the actual dissolved protein concentration is a small 
proportion of the total protein content of the granule.
Another aspect to be considered is the state of the enzyme as it is acting in the 
granule. The preparation used for the experiments described here was a dilute 
aqueous solution of enzyme, which may be relatively vulnerable to effects from 
surrounding molecules, including other proteins. If the enzyme were associated with 
the inner surface of the granule membrane, it may be protected from such 
conformational alterations and thus remain fully active in the presence of high protein 
concentrations. Such a phenomenon could occur through several mechanisms. For 
example, the nature of the interaction between the enzyme molecule and the 
membrane components may increase the structural stability of the enzyme by 
"holding" it in an active conformation. Alternatively, a microenvironment may exist 
close to the membrane surface, due to chemical differences between the lipid 
membrane and the aqueous granule contents, which results in conditions more 
amenable to enzyme activity. Either of these mechanisms may result in continued 
enzyme processing in the presence of high concentrations of hormone and precursor 
molecules. These considerations led to a series of experiments to compare the 














Figure 3.1. The effect of neurophysin concentration on cleavage of OT- 
GKR. 50pM OT-GKR was incubated with 1.5pl (solid circles) or 2.5 pi (open 
circles) of enzyme preparation and increasing concentrations of bovine neurophysin, 
in ImM cobalt chloride, 0.1M ammonium acetate, pH 5.8, in a total volume of 30pl 
at 37°C. After lh, reactions were terminated by addition of 200pl 0.1M HC1, and 
samples analysed by RP-hplc as detailed in Chapter 2. In the absence of neurophysin, 
25% of the substrate was converted to product by 1.5pl enzyme preparation and 41% 
converted by 2.5pl in lh. All values were subjected to arcsin transformation before 














Figure 3.2. The effect of neurophysin concentration on cleavage of oxidised 
OT-GKR. 50pM OT-GKR (solid circles) or 50pM oxidised OT-GKR (open circles) 
were incubated with 1.5pl enzyme preparation under the same conditions as detailed 
















Figure 3.3. The effect of neurophysin in phosphate buffer. 50pM OT-GKR 
was incubated with 1.5pl enzyme preparation and ImM cobalt chloride in 0.1 M 
ammonium acetate (solid circles) or 0.15M sodium phosphate (open circles) at pH 
5.8, 37°C, for lh. Samples were treated as detailed in figure 3.1. In the absence of 














Figure 3.4. The effect of BSA concentration on CPE activity. 50jiM OT- 
GKR (solid circles) and 50|iM oxidised OT-GKR (open circles) were incubated with 
2p,l enzyme preparation and increasing concentrations of BSA, with ImM cobalt 
chloride in 0.1M ammonium acetate, pH 5.8, at 37°C, for lh. Reactions were 
terminated by addition of 200|il 0.1M HC1, and samples analysed by RP-hplc as 
described in Chapter 2. Substrate conversion in the absence of BSA was 25% of the 
cyclic substrate and 32% of oxidised OT-GKR. All values were subjected to arcsin 
transformation before calculation of means and standard errors; n=4.
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Figure 3.5. The effects of various proteins on CPE activity. 50|iM OT- 
GKR was incubated with 2p,l enzyme preparation and ImM cobalt chloride, in the 
presence of 2mg/ml added protein. Assays were conducted in 0.1 M ammonium 
acetate, pH 5.8, at 37°C for lh, then terminated by addition of 200pl 0.1M HC1 and 
samples analysed by RP-hplc as described in Chapter 2. Key to proteins: NP, 
neurophysin; RSP, ribonuclease S protein (Sigma, bovine pancreas); MYO, 
myoglobin (Sigma, horse skeletal muscle); WGA, wheat germ agglutinin (Sigma, 
Tritium vulgaris); BSA, bovine serum albumin (Sigma, 96-99%); COLL, collagen 
(Sigma, human placenta); CAT, catalase (Sigma, bovine liver). Values from 
individual samples were subjected to arcsin transformation before calculation of 













Figure 3.6. The effect of 3-butanol on CPE activity. 50|iM OT-GKR was 
incubated with 2|il enzyme preparation and ImM cobalt chloride, with increasing 
concentrations of 3-butanol. The total reaction volume was 30|il in 0.1 M ammonium 
acetate, pH 5.8, and reactions proceeded for lh at 37°C before termination by 
addition of 200pl 0.1M HC1 and analysis by RP-hplc as detailed in Chapter 2. 
Individual values were subjected to arcsin transformation before calculation of means 














Figure 3.7a. The effect of high neurophysin concentration on CPE activity.
50|iM OT-GKR was incubated with 1.5jil enzyme preparation, ImM cobalt chloride 
and 0, 50 or 500|iM neurophysin (solid circles) or RNase S protein (open circles). 
The total incubation volume was 30pl in 0.1 M ammonium acetate, pH 5.8, and 
reactions were for lh at 37°C. Digestions were halted by the addition of 200jil 0.1M 
HC1, and samples analysed by RP-hplc as described in Chapter 2. Individual results 












Figure 3.7b. The effect of high neurophysin concentration on CPE activity 
against oxidised substrate. 50}iM oxidised OT-GKR was incubated as figure 3.7a; 
n=3 (*n=l; two samples were lost due to a malfunction of the autosample injector).
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Figure 3.7c. The effect of high neurophysin concentration on CPE activity 
with high substrate concentration. 500jiM OT-GKR was incubated as figure 3.7a. 
Reactions were terminated by addition of 1ml 0.1 M HC1, and 200|il each sample 
were analysed; n=3.
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Plate 1. Analysis of the affinity purification of neurophysin by 
polyacrylamide gel electrophoresis. The gel was prepared and electrophoresis 
carried out as described in the text. The samples were lane A: lOng bound fraction 
from affinity column (neurophysin fraction), lane B: 20ng pituitary extract prior to 
affinity purification, lane C: 20ng bound fraction. A larger quantity of the 
neurophysin fraction was applied to lane C so the preparation could be examined for 




COMPARISON OF SOLUBLE AND MEMBRANE-ASSOCIATED 
FORMS OF C ARB OX YPEPTID ASE E
4.1. Introduction
Carboxypeptidase activity on prohormones was shown in early studies to be 
present in both soluble and membrane-associated forms in preparations of adrenal 
medulla (Flicker & Snyder, 1982), insulinoma (Docherty & Hutton, 1983) and 
pituitary cells (Flicker & Snyder, 1982). Subsequent investigations of membrane- 
bound CPE have included pancreatic islet cells (Mackin & Noe, 1987), human 
phaeochromocytoma, mouse, shark and Xenopus brain, and tissues from Aplysia 
(Fricker & Herbert, 1988).
The relative amounts of CPE activity in soluble and membrane fractions varies 
widely both between species (Fricker & Herbert, 1988) and tissues (Strittmatter et al, 
1984 and Supattapone et al, 1984). Lower vertebrates appear to possess a higher 
proportion of membrane-bound enzyme than do mammals (Fricker & Herbert, 1988); 
different regions of rat brain display between 30 and 60% of total CPE activity in the 
membrane form, while the pituitary has less, 26% of activity in the posterior lobe and 
only 10% in the anterior pituitary being found in the insoluble fraction (Supattapone 
e ta l  1984).
92
Characterizations of membrane-associated CPE have shown this form of the 
enzyme to be similar to the soluble form in pH optimum, substrate specificity, 
activation and inhibition (Fricker & Snyder, 1983, Hook, 1984, Supattapone et al, 
1984 and Fricker, 1988c). However, differences in kinetic parameters and an 
increase in total activity on solubilization suggest that although the two forms are 
believed to originate from the same precursor, there may be a difference in specific 
activity caused by interaction with the granule membrane (Fricker, 1988c and Hook, 
1985), or by the presence of the additional sequence which interacts with the 
membrane and accounts for the larger size of the membrane-bound form (Fricker et 
alt 1990).
Association with a membrane can induce profound alteration of many 
characteristics of an enzyme, including kinetics, substrate specificity, cofactor 
requirements and pH optimum, and changes in the properties of the membrane can 
play an important role in regulating enzyme activity (Coleman, 1973). Although the 
membrane-bound form of CPE from bovine pituitary has been characterized (see 
above), this has only been carried out with small, synthetic substrates. In this study it 
was considered important to examine the relative activities of the two forms of 
enzyme against the natural substrate molecule.
4.2. Materials and Methods
4.2.1. Membrane enzyme preparation.
The membrane fraction of the neurosecretory granule preparation described in 
Chapter 2 was used as a source of membrane-associated CPE activity. Fresh
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suspensions of lmg/ml in 0.1M ammonium acetate, pH 5.8, were prepared for each 
investigation, and the mixture vortexed until homogenous.
4.2.2. Adaptations to assay procedure.
The assay procedure described in Chapter 2 for the soluble enzyme preparation 
was adapted for studies of the membrane enzyme preparation. The preparation was 
vortex mixed for 5sec after enzyme had been dispensed to each replicate set (3 or 4) 
of samples, to prevent sedimentation of the membranes. For incubations longer than 
lh, the samples were vortex mixed for 5sec every hour. Finally, reactions were 
terminated by the addition of 210ml 0.1M HC1, vortex mixed, centrifuged in an MSE 
Micro Centaur (11,600 x g for 5min), and 230ml of supernatant removed into a clean 
tube for analysis. The RP-hplc procedure described in Chapter 2 was then followed.
4.3. Results
4.3.1. Characterization of activity in the membrane preparation.
The membrane enzyme preparation (lmg/ml) was shown to cleave the carboxy 
terminal arginine from OT-GKR at a rate of approximately 300pmol/h/mg at pH 5.8, 
37°C, in the presence of ImM cobalt chloride. As for the soluble preparation, the 
membrane enzyme was stimulated by cobalt and inhibited by copper, cadmium, 
EDTA and PCMPS (table 4.1). In the presence of ImM GEMSA, only 5% of the 
carboxypeptidase activity remained.
Detailed pH profiles were obtained for soluble and membrane preparations 
using both acetate and phosphate buffers; both preparations show maximal activity at
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about pH 5.6-5.8 irrespective of the buffer used, although the activity is generally 
slightly higher in acetate than in phosphate except at very low pH. The major 
difference between the two profiles is the maintenance of a high level of activity of 
the membrane preparation at pH values approaching neutrality in acetate buffer 
(figure 4.1a). This was not seen with the soluble preparation in either acetate or 
phosphate (figure 4.1b), nor with the same membrane source in phosphate buffer.
4.3.2. The effect of protein on membrane-associated activity.
On addition of lOmM BSA, the carboxypeptidase activity of the membrane 
preparation was increased to 176% of the control activity; this compares with 
stimulation to 213% of control achieved with the soluble preparation (Chapter 3). In 
the presence of 1.44M t-butanol, however, the membrane preparation was not 
significantly affected, whereas cleavage by the soluble preparation was increased to 
187% of the control value by this treatment.
The presence of RNase S protein in incubations had similar effects on both 
enzyme preparations. While stimulation was seen at 50mM protein, this effect was 
decreased when the concentration of RNase S protein was raised to 500mM (figure 
4.2); this was consistent with the results for the soluble preparation alone in Chapter 
3.
4.3.3. Activity of the membrane preparation against oxidised substrate.
The activities of both enzyme preparations against OT-GKR and oxidised OT- 
GKR were measured over 90min. Both preparations were able to cleave the two 
forms of substrate to similar extents; however the soluble enzyme was more active
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against the linear, oxidised form (figure 4.3a), while the membrane preparation 
processed the cyclic peptide with greater activity (figure 4.3b).
This apparent difference in substrate specificity between the soluble and 
membrane-bound forms of CPE was further examined with respect to pH. The 
soluble enzyme was more active against the oxidised peptide at all three pH values 
tested (4.8, 5.6 and 6.4), although the difference was slightly less at the higher pH 
(figure 4.4a). The membrane preparation, however, displayed a change in specificity 
with pH. At pH 4.8 there was a clear preference for the oxidised substrate; there was 
no significant difference at pH 5.6, and by pH 6.4 the enzyme was more active 
against the native, cyclic substrate (figure 4.4b).
4.4. Discussion
The effects of various activators and inhibitors on the membrane-associated 
form of CPE have been reported to be similar to those on the soluble enzyme (Fricker 
& Snyder, 1982), but figures have only been published for the enzyme purified from 
solubilized membrane (Supattapone et al, 1984). However, despite the difference in 
the preparations used, the results are similar; both studies found similar stimulation of 
both soluble and membrane enzymes by cobalt. Inhibition of the intact membrane 
preparation (this study) and the purified membrane enzyme (Supattapone et al, 1984) 
resulted in the following percentages of control activity respectively: EDTA 23% and 
6%; copper 8% and 10%; cadmium 23% and 19%; PCMPS <5% and 11%. These 
results, together with the pH profile of the membrane-bound enzyme, and the 
reduction of carboxypeptidase activity to 5% in the presence of ljiM GEMS A,
96
confirm the identity of the activity as CPE, and are consistent with published findings 
(Fricker & Snyder, 1982 and Supattapone et al, 1984).
The difference in activities of the soluble and membrane preparations at pH 
values above pH 5.8 (in acetate buffer) may be a result of interaction between 
enzyme and membrane inducing some change in the enzyme itself, or by altering the 
microenvironment around the enzyme. Alternatively, the increase in activity may be 
due to loss of membrane-binding at increasing pH (Fricker et al, 1990), and higher 
specific activity of the solubilized form of CPE increasing the total activity of the 
preparation despite the higher pH. The unusually high activities of both enzyme 
preparations at very low pH in phosphate buffer may be caused by a loss of buffering 
capacity by phosphate at this level.
Stimulation of CPE activity in the membrane preparation by BSA, but not by t- 
butanol, is a very interesting result. The protein effect apparently still operates on the 
membrane-bound enzyme, although the increase in activity is somewhat less than 
with the soluble enzyme, but in this case cannot be attributed to an increase in the 
hydrophobicity of the environment as the membrane-bound enzyme is already in 
association with lipid, and butanol has no effect. If the protein is acting on the two 
enzyme forms in the same manner, this suggests that although there may be some 
contribution by a hydrophobic effect to the activity of the soluble enzyme, this does 
not occur with the membrane enzyme, perhaps because it is already in association 
with hydrophobic membrane components which are fully stimulating the enzyme by 
this mechanism. So the full effect on the membrane enzyme and perhaps a 
significant part of the stimulation of the soluble enzyme is occurring via another 
mechanism, independent of both hydrophobic and sulphydryl components. The
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reduction in stimulation of the membrane enzyme at a higher concentration of protein 
is similar to the effect seen on the soluble enzyme. This rules out a possible 
advantage of membrane binding being to protect the enzyme from the high levels of 
protein in granulo, as suggested in Chapter 3.
A difference demonstrated between the soluble and membrane-bound activities 
was shown by the change in substrate specificity with pH. The efficiency of cleavage 
of the oxidised, linear peptide was greater than that of the cyclic peptide for both 
enzyme preparations up to about pH 5.6. Above this pH, while the specificity of the 
soluble enzyme did not change, the membrane-bound enzyme was more active 
against the native, cyclic peptide. There has been no other difference in substrate 
specificity reported for the two forms of CPE. Oxidation of OT-GKR, which 
converts both cysteine residues to cysteic acid, will clearly affect the pi of the peptide 
molecule, causing it to become more acidic. This may account for a difference in 
processing rates of the two forms of substrate by an enzyme, as both binding and 
catalysis can be influenced by small changes in charge on the substrate molecule. 
However, the change in specificity of the membrane-bound enzyme for these 
substrates at pH 6.4 is not seen with the soluble enzyme and must be due to a 
difference between the two enzyme forms. The possible relevance of this finding to 













Figure 4.1a. pH activity profile of the membrane enzyme preparation.
50|iM OT-GKR was incubated with 2pl membrane enzyme preparation (lmg/ml in 
assay buffer) and ImM cobalt chloride, in 0.1 M ammonium acetate (solid circles) or 
0.15M sodium phosphate (open circles) for lh at 37°C. The total incubation volume 
was 30pl. Reactions were terminated by addition of 110pl 0.1M HC1, and samples 
analysed as described in the text. Results obtained from individual samples were 










Figure 4.1b. pH activity profile of the soluble enzyme preparation. 2.5pl 
soluble enzyme preparation were incubated with 50|iM OT-GKR as figure 4.1a. 
Reactions were terminated by addition of lOOjil 0.1M HC1, and samples analysed as 
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Figure 4.2. Effect of high protein concentration on the membrane enzyme 
preparation. 50pM OT-GKR was incubated with 3|il soluble (solid circles) or 
membrane (open circles) enzyme preparation and ImM cobalt chloride in 0.1 M 
ammonium acetate, pH 5.8, at 37°C for lh. RNase S protein (Sigma) was dissolved 
in assay buffer and added to the stated concentrations, total incubation volume was 
30jil and reactions were terminated by the addition of 200fil 0.1M HC1. Cleavage 
was assessed by RP-hplc analysis of samples. Results of individual samples were 
















Figure 4.3a. Time course of cleavage of cyclic and oxidised OT-GKR by 
the soluble enzyme preparation. 50|iM OT-GKR (solid circles) and 50|iM oxidised 
OT-GKR (open circles) were incubated with 2.5|il soluble enzyme preparation and 
ImM cobalt chloride, in 0.1 M ammonium acetate, pH 5.8. The total volume was 
30|il, and reactions proceeded for lh at 37°C, before termination by addition of 200}il 
0.1M HC1. Samples were analysed by RP-hplc as detailed in Chapter 2. Individual 
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Figure 4.3b. Time course of cleavage of cyclic and oxidised OT-GKR by 
the membrane enzyme preparation. Conditions were as figure 4.3a, with 3pl 
membrane enzyme preparation. Reactions were terminated by addition of 210|il 
0.1M HC1, and samples treated as detailed in the text; n=4.
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Figure 4.4a. Substrate specificity of the membrane enzyme preparation 
with pH. 50|iM OT-GKR (solid circles) and 50pM oxidised OT-GKR (open circles) 
were incubated with 3pl membrane enzyme preparation and ImM cobalt chloride in 
0.1M ammonium acetate at the stated pH values. Total incubation volume was 30pl 
and reactions proceeded for lh at 37°C before termination by addition of 210 fil 
0.1M HC1, and treatment as described in the text. Individual values were subjected to 

















Figure 4.4b. Substrate specificity of the soluble enzyme preparation with
pH. 3fil soluble enzyme preparation was used under the conditions given in figure 
4.4a, and reactions terminated by addition of 200|il 0.1M HC1 before analysis by RP- 
hplc as described in Chapter 2; n=4.
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Treatment % Control Activity
Cobalt chloride ImM 300
EDTA ImM 23
Cadmium chloride O.lmM 23
Copper chloride O.lmM 8
PCMPS ImM <5.0
Table 4.1. Characterization of carboxypeptidase E activity of the 
membrane enzyme preparation. 50|iM OT-GKR was incubated with 3|il 
membrane enzyme preparation (lmg/ml in assay buffer) in 0.1M ammonium 
acetate, pH 5.8, in a total volume of 30pl at 37°C for lh. Reactions were 
terminated by the addition of 210|il 0.1M HC1, and samples analysed by RP-hplc 
as described in the text; n=3.
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CHAPTER 5:
THE CLEAVAGE OF CARBOXY TERMINAL LYSINE BY 
MEMBRANE-ASSOCIATED C ARB OX YPEPTID ASE E
5.1. Introduction
Most investigations into CPE specificity have found this enzyme to display 
higher affinity for arginyl than for lysyl substrates. Early studies of enzyme from 
adrenal, brain and pituitary revealed that Leu- and Met-enkephalin-Arg were more 
potent inhibitors than Leu- or Met-enkephalin-Lys by a factor of three (Fricker & 
Snyder 1982 and Fricker & Snyder 1983). Both soluble and membrane-associated 
CPE from bovine pituitary were found to have twice the affinity for Leu-enkephalin- 
Arg than Leu-enkephalin-Lys (Supattapone et al, 1984). Cleavage rates of the 
oxytocinyl precursor by a neurosecretory granule lysate preparation have been 
reported (Kanmera & Chaiken, 1985a); although 95% of the initial substrate, OT- 
GKR, was converted to OT-GK in 8h under the conditions used, after 96h only 30% 
had been processed to OT-G.
Further evidence for the preference of arginyl substrates by CPE comes from 
inhibitor studies. GEMSA, which mimics the structure of arginine, is 45 times more 
potent an inhibitor of CPE than is APMSA, which is chemically similar to GEMSA, 
but is a structural analogue of lysine (Fricker et al, 1983).
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One study of CPE purified from bovine pituitary and human hepatoma cells 
reported a 2:1 and 3:1 preference, respectively, for furylacrylic-Ala-Lys over 
furylacrylic-Ala-Arg by the two enzyme preparations (Grimwood et al, 1989); this is 
the only report of a preference for a lysyl substrate by CPE.
As removal of lysine from OT-GK is clearly necessary for maturation of the 
oxytocin precursor, this is an important reaction that is often overlooked in 
processing studies, and the lower rates of lysine cleavage that are usually seen have 
not been addressed. As stated in Chapter 2, cleavage of OT-GK was not achieved 
with the soluble enzyme preparation used in this study, although incubation times 
were not extended to 96h as in the report involving similar enzyme and substrate 
preparations where 30% conversion to OT-G was finally achieved (Kanmera & 
Chaiken, 1985). It was surprising, therefore, to discover the capability of the 
membrane enzyme preparation (described in Chapter 4) to cleave OT-GK to OT-G, 
although at a lower rate than the arginine cleavage occurred. This reaction was thus 
characterized to confirm that CPE was responsible for the catalysis, and comparisons 
were made with the conversion of OT-GKR to OT-GK by the same enzyme 
preparation.
5.2. Materials and Methods
The methods used in this chapter have been described in Chapters 2 and 4.
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5.3. Results
5.3.1. Characterization of lysine cleavage by the membrane enzyme 
preparation.
Although cleavage of the carboxy terminal lysine could not be achieved under 
the conditions used with the soluble enzyme preparation (Chapter 2), it was found 
that the membrane preparation described in Chapter 4 was capable of catalysing this 
reaction, although at a much lower rate than the arginine cleavage. Incubations with 
OT-GK were conducted over 3h, and lysine was removed at approximately 
30pmol/3h/|il membrane enzyme preparation, at 37°C in the presence of ImM cobalt 
chloride.
Arginine and lysine cleavages by the membrane enzyme preparation displayed 
similar pH activity profiles (figure 5.1), with highest rates around pH 5.6, declining 
more rapidly at lower values than at those approaching neutrality. These results are 
similar to those for arginine cleavage alone (see Chapter 4).
In the absence of cobalt, no activity could be detected, so it was not possible to 
characterize the lysine cleavage in the same way as removal of arginine had been 
studied for the soluble and membrane preparations (Chapters 2 and 4 respectively). 
However, the activity seen in the presence of cobalt was completely abolished on 
addition of either PCMPS (ImM) or GEMSA (ljiM). When the incubation was 
conducted in the presence of 10|iM BSA, the activity was increased to 240% of the 
control; t-butanol (1.44M) did not affect activity.
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5.3.2. Activity against oxidised substrate.
Under the conditions used for cleavage of the cyclic substrate, cleavage of 
oxidised OT-GK was not detected. However, the enzyme did appear to show some 
affinity for the oxidised form, as cleavage of cyclic peptide was slightly reduced in its 
presence (figure 5.2).
5.4. Discussion
As cleavage of lysine from OT-GK could not be detected in incubations carried 
out in the absence of cobalt, full characterization of this activity was not possible. 
However, the reaction did display many hallmarks of CPE activity, specifically: 
stimulation by cobalt ions (although this effect could not be quantified without a 
control value), optimal activity at pH 5.6, and abolition of cobalt-stimulated activity 
by ImM PCMPS or lfiM GEMSA. This activity against the lysine residue was also 
affected by BSA but not by t-butanol, in a similar manner to the activity of the same 
preparation against carboxy terminal arginine, which was more completely 
characterized as bona fide CPE activity. These results, while not providing 
indisputable evidence of the identity of this enzyme activity, strongly suggest that the 
cleavage observed was due to the action of CPE.
Although the membrane-bound form of CPE may display lower specific activity 
against arginyl substrates than does the soluble form (Hook, 1985 and Fricker,
1988c), this may be compensated for by enhanced removal of the remaining carboxy 
terminal lysine residue. Alternatively, the enzyme may be present in both soluble and
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bound states within the granule to allow cleavage of arginine and lysine by the two 
different forms, respectively.
If the prohormone is initially associated with the inner surface of the granule 
membrane, as discussed in Chapter 4, this could result in much higher activity of the 
membrane bound CPE due to the high local concentration of substrate in this region. 
The higher specific activity of the soluble form was observe^ in vitro^using small, 
synthetic peptide substrates, which would not be expected to form any association 
with a membrane. However, if the native prohormone substrate were already 
attached to the membrane, as is likely following intragranular packaging, 
measurement of relative specific activities of the soluble and bound forms of enzyme 
using small, soluble substrates, would not necessarily be relevant to the in^vivo} 
situation. As detailed in the previous chapter, at the estimated intragranular pH of 
approximately 5.6, a high proportion of CPE would be able to associate with the inner 
membrane surface provided the amphipathic helix region of the enzyme (which is 
responsible for enzyme-membrane binding) had not been cleaved. It is not known 
how much of the enzyme is present in this state in the granules where processing is 
taking place, as some cleavage of this domain may occur during purification of the 
enzyme from granule preparations.
Unless the carboxypeptidase reactions function to limit the quantity of active 
hormone being produced, it would appear illogical to have the enzyme present in a 
form of relatively low activity. Therefore, assuming that a significant proportion of 
CPE remains bound to the granule membrane during processing, it seems possible 
that this binding has a particular function. This may be to allow the enzyme to act on 
locally high concentrations of membrane-associated precursor, or alternatively to
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cause a subtle alteration in the substrate specificity of the enzyme, as seen in Chapter 
4 with cyclic and oxidised forms of OT-GKR, and so increase the efficiency of 
removal of the lysine residue remaining after cleavage of the arginine by the soluble 
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Figure 5.1. pH activity profiles of carboxy terminal arginine and lysine 
cleavages by the membrane enzyme preparation. 50pM OT-GKR (solid circles) 
or 50pM OT-GK (open circles) were incubated with 5pl membrane enzyme 
preparation and ImM cobalt chloride in 0.1 M ammonium acetate at the stated pH 
values. Total incubation volume was 30pl and reactions proceeded at 37°C for lh for 
OT-GKR and 3h for OT-GK. Cleavage was halted by the addition of 210 pi 0.1M 
HC1 and samples were analysed as described in the text. Individual results were 















Figure 5.2. The effect of oxidised OT-GK on the cleavage of cyclic OT-GK 
by the membrane enzyme preparation. 50|iM OT-GK were incubated with 5|il 
membrane enzyme preparation and ImM cobalt chloride in the presence (squares) 
and absence (circles) of 50|iM oxidised OT-GK. The total volume was 30|il with
0.1M ammonium acetate, pH 5.8; samples were incubated at 37°C and mixed every 
hour. At the stated times, reactions were stopped by addition of 210}il 0.1M HC1, and 
samples treated and analysed as detailed in the text. Individual values were subjected 




The work contained within this study has resulted in four significant 
observations:
1. CPE activity is influenced by the presence of protein;
2. Inhibition of CPE activity by high concentrations of neurophysin is not 
related to neurophysin-substrate binding;
3. The soluble and membrane-bound forms of CPE display different substrate 
specificities at certain pH values;
4. The membrane-bound preparation of CPE used in this study was more 
efficient than the soluble form in the cleavage of carboxy terminal lysine.
Studies of some hydroxylase enzymes have shown stimulation of activity by 
added protein (see section 3.1), but such effects on CPE by a wide range of proteins 
has not been previously reported. The increase in activity of proline hydroxylase 
seen on the addition of BSA and some other proteins was concluded in some reports 
to be mainly due to a sulphydryl effect, as proteins lacking in cysteine were not 
stimulatory, and the effect of BSA could be abolished by treating it to remove free 
sulphydryl groups, or largely substituted by sulphydryl reagents such as dithiothreitol 
(Rhoads et al, 1967 and Rhoads & Udenfriend, 1970). In the case of CPE, however,
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all the proteins tested, whether or not they contained cysteine residues, had similar 
effects on enzyme activity (see Chapter 3). Unlike proline hydroxylase, the CPE 
preparation was not stimulated by the addition of thiol groups in the form of 
dithiothreitol or L-cysteine. An attempt was made to treat BSA to remove free 
sulphydryl groups so that this could be tested in the assay system; amino acid 
analysis, however, proved the reaction to have been unsuccessful.
Despite being unable to test the effects of BSA without thiol groups, the 
evidence gained from these experiments suggests that the protein effect on CPE 
activity is not due to stimulation by sulphydryl groups. Studies by Popenoe et al 
(1969) on proline hydroxylase suggested that only a small amount of stimulation of 
this enzyme by BSA was due to a thiol effect, but no alternative mechanism was 
proposed. Stimulation of phenylalanine hydroxylase by BSA was shown to be 
unrelated to sulphydryl availability, but probably resulted from binding of excess 
ferrous ions which could otherwise inhibit the enzyme (Guroff et al, 1970). 
Tryptophan hydroxylase is stimulated by BSA, and although the activity of this 
enzyme is also increased in the presence of dithiothreitol (Jequier et al, 1969), protein 
was not thought to affect the enzyme directly, by contributing sulphydryl groups (as 
highly purified enzyme is unaffected by BSA), but was believed to either stabilise the 
enzyme in crude preparations, or to remove an inhibitory component of such mixtures 
by binding to it (Hori & Ohotami, 1978). The CPE preparation which was used for 
the experiments detailed in this report was not highly purified, however any metals 
which could be inhibiting the enzyme and bound by BSA, for example copper, should 
have been removed by gel filtration. Despite this assumption, studies with BSA and 
metals such as copper may prove worthwhile. The possibility of a different inhibitory
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compound remaining in the enzyme preparation after gel filtration, which can 
subsequently be removed by binding to BSA, could be investigated by testing for any 
effect of BSA on more highly purified preparations of CPE.
The activity of CPE in the presence of neurophysin has been previously 
examined as discussed in Chapter 3. Similar results are described here for low 
concentrations of neurophysin, which cause a non-specific enhancement of enzyme 
activity which is unrelated to neurophysin-substrate binding, and can be achieved 
with a wide range of proteins.
At higher concentrations of neurophysin, however, the observations detailed 
here led to different conclusions of how inhibition of activity occurs, when compared 
with published findings. In a previous report, while a high concentration of 
neurophysin was found to inhibit CPE activity, RNase S protein was not seen to 
reduce the reaction rate when added at any concentration (Ando et al, 1988). This led 
the authors to conclude that binding between neurophysin and the peptide substrate, 
combined with dimerisation of such complexes, resulted in stearic constraints on 
enzymatic processing of the peptide and thus led to a reduced reaction rate. In the 
present study, however, high concentrations of either protein resulted in similar 
degrees of reduced stimulation or inhibition of activity of both the soluble and 
membrane-bound preparations of CPE. The observation that activity against the 
oxidised peptide was equally affected shows conclusively that the mechanism of 
inhibition cannot be related to binding between neurophysin and substrate, as it was 
shown that oxidation prevented OT-GKR from binding to neurophysin. This 
conclusion is important if the strategy outlined in Chapter 1 is to be followed, that is, 
to attempt to study processing reactions under conditions approaching those found in
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vivo. As the concentration of neurophysin within the neurosecretory granule is very 
high (0.06M, Nordmann & Morris, 1984), this would potentially be a major problem 
if neurophysin was indeed specifically inhibiting processing activity by binding the 
substrate. However, if the inhibition is non-specific, as suggested by this work, it 
may be that manipulation of other factors will overcome this problem and allow 
processing to be studied under the desired conditions.
The use of Southern blotting has established the presence of a single gene for 
CPE (Flicker et al, 1986), which is believed to code for a precursor molecule that is 
processed to the active, membrane-bound form (with the anchor region at the amino 
terminus) and then further cleaved to produce the soluble enzyme (Flicker, 1988b). 
Tissue extracts from various species reveal differing proportions of the two forms, 
and the function of membrane binding has not been established. Initial comparisons 
suggested that the soluble enzyme possessed higher specific activity, so membrane- 
association could be necessary for correct compartmentalization before cleavage to 
the soluble form for full activity occurred, alternatively it could be a mechanism to 
control CPE activity within the granule, by regulating the proportion of bound and 
free types (Fricker, 1988c). This study has shown differences in the characteristics of 
the two forms of CPE, both in response to changing environmental conditions (pH), 
and relative cleavage rates of arginyl and lysyl substrates; this introduces the 
possibility of different roles for the two forms of enzyme. Neurophysin has been 
isolated both in association with membrane lipids (Audhya & Walter, 1979) and 
membranes from neurosecretory granules (Swann & Pickering, 1976). It appears 
likely that the newly-formed granule contains both proenzyme and prohormone 
bound to the inner surface of the membrane; the proenzyme bound by the amino
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terminal "amphiphilic helix", and the prohormone by associations between the 
neurophysin domain and membrane components. Cleavage of the carboxy terminal 
region of proCPE results in the active, membrane-bound form of the enzyme; 
endoprotease cleavage of prooxytocin may leave neurophysin in association with the 
membrane, also binding the extended hormone sequence, keeping it close to the 
processing enzyme on the inner surface of the granule. Much of the processing in 
vivo could thus be taking place at the membrane, but is not easily studied by 
disruption of the granules and separation of soluble and membrane components. This 
model would provide a function for neurophysin in retaining the extended forms of 
oxytocin and vasopressin close to the membrane surface after endoproteolytic 
cleavage has occurred, and may be an important area for further experimentation.
The findings of this study therefore have several implications for future 
investigations. The influence of protein concentration on the activity of CPE should 
be considered when in vitro studies of this and other processing enzymes are 
designed, with particular consideration given to the concentration found at the in vivo 
site of enzyme action. The presence of membrane components, and interactions 
between enzymes and granule membranes are also relevant in such studies, as this 
work has shown that such factors can alter enzyme characteristics, perhaps leading to 
different roles for soluble and membrane-associated forms of the same enzyme. 
Subtle changes in enzyme structure and microenvironment brought about by 
membrane binding may also help to overcome current problems of pH 
incompatability between purified processing enzymes, allowing complete processing 
of a prohormone by several different enzymes under a common set of conditions.
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This study has shown that CPE activity is indeed influenced by environmental 
factors that are likely to be operating to some extent in vivo. These findings should 
be considered and persued in order to develop realistic investigations of how 
prohormone processing occurs within the cell.
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APPENDIX
Automatic Sample Injector Programme
1 RACK CODE 0
2 INPUT BO/1
3 IF B0>80
4 GO TO 2
5 INPUT B2/30
6 IF B2>425


































Information entered for each run:
BO: number of samples (1-80)
B2: sample volume (typically 200|il)
B3: injection valve rinse volume (500|il)
B4: needle rinse volume
B5: cycle time for sample injector (27min)
This programme instructs the auto-sample injector to deliver samples for 
analysis in the following way. The samples (typically 230|il) are held in the 1.5ml 
polypropylene microcentrifuge tubes used for the assays, suspended in a rack of 
known dimensions. To prevent mixing of the sample with water in the sample 
tubing, 15|xl of air are first aspirated into the tubing, followed by 215pl of sample.
The needle moves to the injection port and 15jj1 of sample are dispensed with the 
injection valve in the "inject" position (by-passing the sample loop), to wash the 
system with the sample. The valve then moves to the "load" position, and the 
remaining 200|il of sample are dispensed into the sample loop. When a signal is 
received from the controller (the Gilson 714 programme on the PC) that the elution 
gradient has begun, the valve moves to the "inject" position, causing the mobile phase 
to flow through the sample loop and deliver the sample to the column. The needle 
and tubing are rinsed, and the system waits 27 minutes before repeating the cycle.
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